ESAB (ESAB) 10-K29 Feb 242023 FY Annual reportFinancial data

Company Profile

COVER PAGE

COVER PAGE - USD ($) $ in Millions	12 Months Ended
COVER PAGE - USD ($) $ in Millions	Dec. 31, 2023	Feb. 22, 2024	Jun. 30, 2023
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2023
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-41297
Entity Registrant Name	ESAB CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0923837
Entity Address, Address Line One	909 Rose Avenue 8th Floor
Entity Address, City or Town	North Bethesda
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	20852
City Area Code	301
Local Phone Number	323-9099
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	ESAB
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 4,010
Entity Common Stock Shares Outstanding		60,337,308
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference from the Registrant’s definitive proxy statement for its 2024 annual meeting of stockholders (the “2024 Proxy Statement”) to be filed pursuant to Regulation 14A within 120 days after the end of the Registrant’s fiscal year covered by this report. With the exception of the sections of the 2024 Proxy Statement specifically incorporated herein by reference, the 2024 Proxy Statement is not deemed to be filed as part of this Form 10-K.
Entity Central Index Key	0001877322
Amendment Flag	false
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023

AUDIT INFORMATION

AUDIT INFORMATION	12 Months Ended
AUDIT INFORMATION	Dec. 31, 2023
Auditor Information [Abstract]
Auditor Name	Ernst & Young LLP
Auditor Location	Tysons, Virginia
Auditor Firm ID	42

CONSOLIDATED AND COMBINED STATE

CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net sales	$ 2,774,766	$ 2,593,480	$ 2,428,115
Cost of sales	1,759,015	1,707,950	1,590,132
Gross profit	1,015,751	885,530	837,983
Selling, general and administrative expense	587,475	533,369	512,815
Restructuring and other related charges	24,110	23,096	18,954
Operating income	404,166	329,065	306,214
Pension settlement gain	0	(9,136)	(11,208)
Interest expense (income) and other, net	85,074	37,950	(1,666)
Income from continuing operations before income taxes	319,092	300,251	319,088
Income tax expense	95,727	69,170	80,409
Net income from continuing operations	223,365	231,081	238,679
Loss from discontinued operations, net of taxes	(12,341)	(3,068)	0
Net income	211,024	228,013	238,679
Less: Income attributable to noncontrolling interest, net of taxes	5,739	4,266	3,569
Net income attributable to ESAB Corporation		$ 223,747	$ 235,110
Net income attributable to ESAB Corporation	$ 205,285
Earnings (loss) per share - basic
Income from continuing operations (in dollars per share)	$ 3.59	$ 3.75	$ 3.92
Loss on discontinued operations (in dollars per share)	(0.20)	(0.05)	0
Net income per share (in dollars per share)	3.39	3.70	3.92
Earnings (loss) per share - diluted
Income from continuing operations (in dollars per share)	3.56	3.74	3.92
Loss on discontinued operations (in dollars per share)	(0.20)	(0.05)	0
Net income per share - diluted (in dollars per share)	$ 3.36	$ 3.69	$ 3.92

CONSOLIDATED AND COMBINED STA_2

CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 211,024	$ 228,013	$ 238,679
Other comprehensive income (loss):
Foreign currency translation, net of tax expense (benefit) of $4,545, $(2,930) and $740	47,258	(175,719)	(72,398)
Unrealized (loss) gain on derivatives designated and qualifying as cash flow hedges, net of tax (benefit) expense of $(1,087) and $3,240	(3,732)	11,102	0
Defined benefit pension and other post-retirement plan activity, net of tax expense (benefit) of $2,639, ($1,840) and ($1,192)	7,338	6,192	6,657
Other comprehensive income (loss)	50,864	(158,425)	(65,741)
Comprehensive income	261,888	69,588	172,938
Less: comprehensive income attributable to noncontrolling interest	5,887	678	2,513
Comprehensive income attributable to ESAB Corporation	$ 256,001	$ 68,910	$ 170,425

CONSOLIDATED AND COMBINED STA_3

CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Foreign currency translation, tax expense (benefit)	$ 4,545	$ (2,930)	$ 740
Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense (benefit)	(1,087)	3,240
Defined benefit pension and other post-retirement plan activity, net of tax expense (benefit)	$ 2,639	$ (1,840)	$ (1,192)

CONSOLIDATED AND COMBINED BALAN

CONSOLIDATED AND COMBINED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 102,003	$ 72,024
Trade receivables, less allowance for credit losses of $25,477 and $23,471	385,198	374,329
Inventories, net	392,858	416,829
Prepaid expenses	61,771	56,637
Other current assets	55,890	68,851
Total current assets	997,720	988,670
Property, plant and equipment, net	294,305	284,226
Goodwill	1,588,331	1,529,767
Intangible assets, net	499,535	517,167
Lease asset - right of use	95,607	92,033
Other assets	353,131	342,152
Total assets	3,828,629	3,754,015
CURRENT LIABILITIES:
Accounts payable	306,593	316,265
Accrued liabilities	313,489	285,310
Total current liabilities	620,082	601,575
Long-term debt	1,018,057	1,218,643
Other liabilities	542,833	545,339
Total liabilities	2,180,972	2,365,557
Equity:
Common stock - $0.001 par value - Authorized 600,000,000; 60,295,634 and 60,094,725 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	60	60
Additional paid-in capital	1,881,054	1,865,904
Retained earnings	350,557	159,231
Accumulated other comprehensive loss	(624,272)	(674,988)
Total ESAB Corporation equity	1,607,399	1,350,207
Noncontrolling interest	40,258	38,251
Total equity	1,647,657	1,388,458
Total liabilities and equity	$ 3,828,629	$ 3,754,015

CONSOLIDATED AND COMBINED BAL_2

CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical] - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 25,477	$ 23,471
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	600,000,000	600,000,000
Common stock, shares issued (in shares)	60,295,634	60,094,725
Common stock, shares outstanding (in shares)	60,295,634	60,094,725

CONSOLIDATED AND COMBINED STA_4

CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Retained Earnings	Former Parent’s Investment	Accumulated Other Comprehensive Loss	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2020		0
Beginning balance at Dec. 31, 2020	$ 2,544,767	$ 0	$ 0	$ 0	$ 2,898,831	$ (396,203)	$ 42,139
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	238,679				235,110		3,569
Distributions to noncontrolling owners	(3,713)						(3,713)
Other comprehensive income (loss), net of tax	(65,741)					(64,685)	(1,056)
Former Parent Common stock-based award activity	6,267				6,267
Transfers to Former Parent, net	(218,531)				(218,585)		54
Ending balance (in shares) at Dec. 31, 2021		0
Ending balance at Dec. 31, 2021	2,501,728	$ 0	0	0	2,921,623	(460,888)	40,993
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	228,013			168,310	55,437		4,266
Distributions to noncontrolling owners	(3,420)						(3,420)
Other comprehensive income (loss), net of tax	(158,425)					(154,837)	(3,588)
Dividends declared	(9,079)			(9,079)
Former Parent Common stock-based award activity	1,728				1,728
Transfers to Former Parent, net	(1,200,000)				(1,200,000)
Net Transfers from Former Parent, including Separation Adjustments	15,726		4,346		70,643	(59,263)
Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent (in shares)		60,034,311,000
Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent	0	$ 60	1,849,371		(1,849,431)
Common stock-based award activity (in shares)		60,414,000
Common stock-based award activity	$ 12,187		12,187
Ending balance (in shares) at Dec. 31, 2022	60,094,725	60,094,725,000
Ending balance at Dec. 31, 2022	$ 1,388,458	$ 60	1,865,904	159,231	0	(674,988)	38,251
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	211,024			205,285	0		5,739
Distributions to noncontrolling owners	(3,880)						(3,880)
Other comprehensive income (loss), net of tax	50,864					50,716	148
Dividends declared	(13,959)			(13,959)
Common stock-based award activity (in shares)		200,909,000
Common stock-based award activity	$ 15,150		15,150
Ending balance (in shares) at Dec. 31, 2023	60,295,634	60,295,634,000
Ending balance at Dec. 31, 2023	$ 1,647,657	$ 60	$ 1,881,054	$ 350,557	$ 0	$ (624,272)	$ 40,258

CONSOLIDATED AND COMBINED STA_5

CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Stockholders' Equity [Abstract]
Other comprehensive income (loss), tax	$ (6,097)	$ 1,530	$ 452
Dividends on common stock (in dollars per share)	$ 0.23	$ 0.15

CONSOLIDATED AND COMBINED STA_6

CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income	$ 211,024	$ 228,013	$ 238,679
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other impairment charges	75,034	65,978	75,899
Stock-based compensation expense	16,122	12,964	6,267
Deferred income tax	(25,408)	(20,199)	(8,644)
Non-cash interest expense	1,195	1,972	0
Pension settlement gain	0	(9,136)	(11,208)
Changes in operating assets and liabilities:
Trade receivables, net	(6,006)	(8,142)	(67,850)
Inventories, net	17,958	(10,066)	(117,350)
Accounts payable	(19,819)	(28,794)	114,502
Other operating assets and liabilities	60,394	(18,232)	20,442
Net cash provided by operating activities	330,494	214,358	250,737
Cash flows from investing activities:
Purchases of property, plant and equipment	(48,178)	(40,243)	(35,584)
Proceeds from sale of property, plant and equipment	4,600	4,849	5,204
Acquisitions, net of cash received	(18,665)	(149,029)	(4,885)
Net cash used in investing activities	(62,243)	(184,423)	(35,265)
Cash flows from financing activities:
Proceeds from borrowings on term credit facility	0	1,000,000	0
Repayments of borrowings on term credit facility	(12,500)	0	0
Proceeds from borrowings on revolving credit facility and other	574,150	805,881	673
Repayments of borrowings on revolving credit facility and other	(763,173)	(585,491)	0
Payment of deferred financing fees and other	(972)	(4,706)	0
Payment of deferred consideration	0	(1,500)	0
Payment of dividends	(13,342)	(6,054)	0
Consideration to Former Parent in connection with the Separation	0	(1,200,000)	0
Distributions to noncontrolling interest holders	(3,880)	(3,420)	(3,713)
Transfers from (to) Former Parent, net	0	2,847	(218,531)
Net cash provided by (used in) financing activities	(219,717)	7,557	(221,571)
Effect of foreign exchange rates on Cash and cash equivalents	(18,555)	(6,677)	(1,901)
Increase (decrease) in Cash and cash equivalents	29,979	30,815	(8,000)
Cash and cash equivalents, beginning of period	72,024	41,209	49,209
Cash and cash equivalents, end of period	102,003	72,024	41,209
Supplemental disclosures:
Interest payments, net	79,148	34,678	0
Income tax payments, net	$ 132,902	$ 85,659	$ 0

Organization and Basis of Prese

Organization and Basis of Presentation	12 Months Ended
Organization and Basis of Presentation	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	Organization and Basis of Presentation Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a focused premier industrial compounder. ESAB provides its partners with fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company’s rich history of innovative products, workflow solutions and its business system, ESAB Business Excellence System (“EBX”), enables the Company’s purpose of Shaping the world we imagine TM . The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter. Separation from Enovis On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax,” “Enovis” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the spin-off and related distribution, collectively, the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. Upon completion of the Distribution, Colfax changed its name to Enovis Corporation and continued to hold 10% of the outstanding common stock of ESAB. In November 2022, Enovis sold a total of 6.0 million shares of the Company’s common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of the Company’s outstanding common stock. In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Separation Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement and license agreement for the EBX. Russia and Ukraine Conflict The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, t he Company is meeting current contractual obligations w hile addressing applicable laws and regulations. For the year ended December 31, 2023, Russia represented approximately 6% of the Company’s total revenue, and approximately $12 million of its Net income. Russia also has approximatel y 4% of the Company’s total net assets excluding any goodwill allocation as of December 31, 2023. I n case of the disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of at the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $115 million as of December 31, 2023, which could be realized upon a transition out. The C ompany is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations. Basis of Presentation The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The combined financial statements for periods prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Re lated party a llocations prior to the Separation, including the method for such allocation, are discussed further in Note 21, “Related Party Transactions.” Following the Separation, the consolidated financial statements include ESAB and its wholly-owned subsidiaries and no longer include any allocations of expenses from Enovis. Accordingly: • The Consolidated Balance Sheets as of December 31, 2023 and December 31, 2022 con sist of the consolidated balances of ESAB. • The Consolidated Statement of Operations, Statement of Comprehensive Income (Loss), Statement of Changes in Equity and Statement of Cash Flows for the year ended December 31, 2023 consist of the consolidated results of ESAB. • The Consolidated and Combined Statement of Operations, Statement of Comprehensive Income (Loss), Statement of Changes in Equity and Statement of Cash Flows for the year ended December 31, 2022 consist of the activities of ESAB for the nine months ended December 31, 2022 and the combined activity of the former Fabrication Technology business of Enovis for the three months ended April 1, 2022. • The Consolidated and Combined Statement of Operations, Statement of Comprehensive Income (Loss), Statement of Changes in Equity and Statement of Cash Flows for the year ended December 31, 2021 consist of the combined activity of the former Fabrication Technology business of Enovis. Our Consolidated and Combined Financial Statements may not be indicative of the Company's results had it been a separate stand-alone entity throughout the periods pre-separation presented, nor are the results stated herein indicative of what the Company's financial position, results of operations and cash flows may be in the future. Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements under Enovis’s centralized approach to cash management and financing of its operations. With the exception of cash, cash equivalents and borrowings clearly associated with ESAB and related to the Separation, financing transactions relating to the Company during the period prior to the Separation were accounted for through the Former Parent’s investment account of the Company. Accordingly, none of Enovis’s cash, cash equivalents or debt at the corporate level has been assigned to the Company in these financial statements. Former Parent’s Investment, which included retained earnings, represented Enovis’s interest in the recorded net assets of the Company. All significant transactions between the Company and the Former Parent prior to the Separation have been included in the accompanying Financial Statements. Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Transfers to Former Parent, net” for the year ended December 31, 2021, and “ Net Transfers from Former Parent, including Separation Adjustments” for the year ended December 31, 2022. The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation. The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates. These Consolidated and Combined Financial Statements included in this annual report have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) in conformity with GAAP, for the preparation of the Consolidated and Combined Financial Statements.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Principles of Consolidation The Company’s Consolidated and Combined Financial Statements are prepared in accordance with GAAP and include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed in order to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest. All significant intercompany accounts and transactions have been eliminated. Equity Method Investments Investments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value. Revenue Recognition The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services. The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers , to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time. As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 6, “Revenue” and Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances and related information. The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred. Taxes Collected from Customers and Remitted to Governmental Authorities The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated Balance Sheets until remitted to the respective taxing authority. Research and Development Expense Research and development costs of $38.8 million , $36.0 million and $39.7 million for the years ended December 31, 2023, 2022 and 2021, respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects. Cash and Cash Equivalents Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less. Trade Receivables Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically. Inventories Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost for a substantial portion of United States inventories is determined using the last-in, first-out (“LIFO”) method. The value of inventory stated on a LIFO basis as of December 31, 2023 and 2022 was $107.8 million and $131.1 million, respecti vely. The valuation of LIFO inventories is made at the end of each year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out basis. Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $47.6 million and $40.1 million as of December 31, 2023 and 2022, respectively. Property, Plant and Equipment Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions and depreciated by the straight-line method over the estimated useful lives of the related assets. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset. Impairment of Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company. The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”). In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value. When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business. For the year ended December 31, 2023 and 2022, a qualitative Goodwill impairment assessment was performed for the three reporting units. For the year ended December 31, 2021, a quantitative annual impairment test of Goodwill was performed for the GCE reporting unit while qualitative assessments were performed for the remaining two reporting units. All of the above tests indicated no impairment existed. Therefore, no impairment charges were recorded for the three years ended December 31, 2023. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2023 annual impairment test. In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2023, 2022 and 2021, all of which indicated no impairment existed. Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from ten The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. The Company determined that no significant impairment indicators were evident during the years ended December 31, 2023, 2022 and 2021. Derivatives The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes. All derivatives are recognized at fair value on the Company’s Consolidated Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued. The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty. Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive income ("AOCI") with offsetting amounts recorded in the Company’s Consolidated Balance Sheet depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. Certain cross-currency swap agreements are designated and qualify as a net investment hedge, the changes in the fair value of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. Offsetting amounts are recorded in the Company’s Consolidated Balance Sheet depending on the position and the duration of the contract. The Company has certain foreign currency contracts which are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense (income) and other, net, in the Company’s Consolidated and Combined Statement of Operations. Warranty Costs Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency and average costs of warranty claims. Income Taxes Prior to the Separation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. Prior to the Separation, all or a portion of the Company’s income tax payable or receivable computed under the separate return method was adjusted to equity as it did not represent a liability or asset with the relevant taxing authorities during this period, except for certain unrecognized tax benefits for which ESAB could have reasonably been considered to be the primary obligor. The amounts were deemed settled with Enovis when they were due and therefore were included in Parent’s equity. The Company accounts for income taxes under ASC 740 , Income Taxes (“ASC 740”) which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income is accounted for as a current tax expense in the year the tax is incurred. Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets. The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations. Interest expense (income) and Other, Net Interest expense (income) and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest income or expense of derivatives designated in hedging relationships. In addition, it is comprised of: • other non-operating expense (income) items, including certain pension-related activities, • foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships, and • Argentina highly inflationary accounting transaction foreign exchange loss on cash and cash equivalent remeasured into the Argentinian entity’s Brazilian real direct parent’s currency. For the years ended December 31, 2023 and 2022, Argentina had a transaction exchange loss on cash and cash equivalent of $26.2 million , and $2.4 million, partially offset by interest income of $8.7 million and $0.7 million, respectively. For the year ended December 31, 2021 , the impact was not material. See “Foreign Currency Exchange Gains and Losses” and “Argentina Highly Inflationary Accounting” policies below for additional information. Foreign Currency Exchange Gains and Losses The Company’s financial statements are presented in U.S. dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation are net of income taxes to the extent the unrealized foreign exchange is taxed currently or the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year. Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated Balance Sheets are recognized in Selling, general and administrative expense or Interest expense (income) and other, net in the Consolidated and Combined Statements of Operations for that period. The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations: Year Ended December 31, 2023 2022 2021 (In thousands) (1) Selling, general and administrative expense $ 11,389 $ 2,597 $ 2,195 Interest expense and other, net 1,719 109 191 Foreign currency transaction loss, net (2) $ 13,108 $ 2,706 $ 2,386 (1) This table excludes the foreign exchange impacts of applying highly inflationary accounting for the Company’s Argentina operations for the years ended December 31, 2023 and 2022, as described in the “Argentina Highly Inflationary Accounting” paragraph below. (2) During 2023, the weakening of the Ruble and certain other South American currencies drove the increase in the loss on transactions denominated in foreign currencies. Argentina Highly Inflationary Accounting Argentina is deemed to have a highly inflationary economy, resulting in the remeasurement of the Company’s Argentinian operations into Brazilian real, the functional currency of the Argentinian entity’s direct parent. Gains and losses from the remeasurement are recorded in the Company’s Consolidated and Combined Statements of Operations each year. In December 2023, the Argentine peso significantly devalued due to changes in their foreign exchange policy introduced by the Argentine government. For the year ended December 31, 2023 the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign exchange loss to Cost of sales of $11.5 million, Selling, general and administrative gain of $6.7 million and Interest (income) expense and other, net loss of $26.2 million. Despite the above transaction foreign exchange loss, the Argentine subsidiary has taken pricing and operational actions to remain profitable. For the year ended December 31, 2022, the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign exchange loss to Cost of sales of $6.6 million, Selling, general and administrative expense of $3.3 million and Interest (income) expense and other, net loss of $2.4 million. The impact to the Company’s Combined Statements of Operations for the year ended December 31, 2021 was not material. Use of Estimates The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	12 Months Ended
Recently Issued Accounting Pronouncements	Dec. 31, 2023
Accounting Policies [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements The Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined financial statements as well as material updates to previous assessments. There were no new material accounting standards adopted in the year ended December 31, 2023 that impacted the Company. New Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires the disclosure of incremental information about significant segment expenses. The guidance also requires disclosure of the Chief Operating Decision Maker’s (the “CODM”) position for each segment and detail of how the CODM uses financial reporting to assess their segment’s performance. The new guidance is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024. The Company is currently evaluating the effect the adoption of the ASU may have on its disclosures. In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures , which expands disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. The ASU is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect the adoption of the ASU may have on its disclosures.

Discontinued Operations

Discontinued Operations	12 Months Ended
Discontinued Operations	Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses that it does not have an interest in the ongoing operations. The entities that hold these assets and liabilities became subsidiaries of the Company in connection with the Separation. These contributions from the Former Parent wer e not previously included in the Company’s 2019 to 2021 historical carve-out financial statements. The Company has classified asbestos-related activity included in its Consolidated and Combined Statements of Operations as part of Loss from discontinued operations, net of taxes. Loss from discontinued operations, net of tax consisted of Selling, general and administrative expenses of $15.6 million net of a tax benefit of $3.3 million for the year ended December 31, 2023. Loss from discontinued operations, net of tax consisted of Selling, general and administrative expenses of $7.5 million net of a tax benefit of $4.4 million for the year ended December 31, 2022. See Note 19, “Commitments and Contingencies” for further information. Cash used in operating activities related to discontinued operations for the year ended December 31, 2023 was $15.2 million and for the year ended December 31, 2022 was $23.1 million.

Acquisitions

Acquisitions	12 Months Ended
Acquisitions	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions The Company continually evaluates potential acquisitions that either strategically fit with our existing portfolio or expand our portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for under the acquisition method of accounting. The Company makes an initial allocation of the purchase price at the date of acquisition based upon our understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. As the Company obtains additional information about these assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, the Company is able to refine the estimates of fair value and more accurately allocate the purchase price. The Company makes appropriate adjustments to purchase price allocations prior to completion of the applicable measurement period, as required. The following briefly describes our acquisition activity for the three years ended December 31, 2023. On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for $19 million, net of cash received. On October 31, 2022, the Company completed the acquisition of Swift Cut Automation Limited, a provider of light industrial cutting systems, for $22 million, net of cash received. This acquisition provides a market-leading automated cutting portfolio. On October 14, 2022, the Company completed the acquisition of Ohio Medical, LLC, a United States based global leader in oxygen regulators and central gas systems, for $127 million, net of cash received. This acquisition expands the Company’s presence in industrial specialty gas applications and products and broadens the Company’s United States presence.

Revenue

Revenue	12 Months Ended
Revenue	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The Company provides fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the following product groups: Year Ended December 31, 2023 2022 2021 (In thousands) Equipment $ 854,949 $ 740,824 $ 758,267 Consumables 1,919,817 1,852,656 1,669,848 Total $ 2,774,766 $ 2,593,480 $ 2,428,115 The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products. Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of December 31, 2023 is immaterial. In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2023, 2022 and 2021, total contract liabilities were $31.2 million , $25.9 million and $22.3 million, respectively, and are included in Accrued liabilities on the Consolidated Balance Sheets. During the years ended December 31, 2023 and 2022, substantially all amounts included in the contract liability balance at the beginning of the respective year were recognized as revenue in the following year. Allowance for Credit Losses A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated Balance Sheets is as follows: Year Ended December 31, 2023 Balance at Charged to Expense, net Write-Offs and Deductions Foreign Balance at (In thousands) Allowance for credit losses $ 23,471 $ 3,902 $ (2,289) $ 393 $ 25,477

Earnings per Share from Continu

Earnings per Share from Continuing Operations	12 Months Ended
Earnings per Share from Continuing Operations	Dec. 31, 2023
Earnings Per Share [Abstract]
Earnings per Share from Continuing Operations	Earnings per Share from Continuing Operations The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends that are considered participating securities. The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows: Year Ended December 31, 2023 2022 2021 (In thousands, except share and per share data) Computation of earnings per share from continuing operations - basic: Income from continuing operations attributable to ESAB Corporation (1) $ 217,626 $ 226,815 $ 235,110 Less: distributed and undistributed earnings allocated to nonvested shares (1,555) (1,600) — Income from continuing operations attributable to common stockholders $ 216,071 $ 225,215 $ 235,110 Weighted-average shares of Common stock outstanding – basic (2) 60,233,623 60,054,930 60,034,311 Income per share from continuing operations – basic $ 3.59 $ 3.75 $ 3.92 Computation of earnings (loss) per share from continuing operations - diluted: Income from continuing operations attributable to common stockholders $ 216,071 $ 225,215 $ 235,110 Weighted-average shares of Common stock outstanding – basic (2) 60,233,623 60,054,930 60,034,311 Net effect of potentially dilutive securities (3) 422,123 98,129 — Weighted-average shares of Common stock outstanding – dilution 60,655,746 60,153,059 60,034,311 Net income per share from continuing operations – diluted $ 3.56 $ 3.74 $ 3.92 (1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, o f $5.7 million, $4.3 million and $3.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. (2) The total number of shares outstanding on April 4, 2022 was 60,034,311, which is utilized for the calculation of both basic and diluted earnings per share for the year ended December 31, 2021 as no ESAB common stock equivalents were outstanding prior to the Separation. (3) Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Separation from Enovis Prior to the Separation, our operating results were included in the Former Parent’s various consolidated United States federal and certain state income tax returns, as well as certain non-United States returns. For periods prior to the Separation, our combined financial statements reflect Income tax expense and deferred tax balances as if we had filed tax returns on a standalone basis separate from the Former Parent. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if we were a separate taxpayer and a standalone enterprise for the periods prior to the Separation. For periods prior to the Separation, our pretax operating results include any transactions with the Former Parent as if it were an unrelated party. In connection with the Separation, we entered into agreements with the Former Parent, including a Tax Matters Agreement. The Tax Matters Agreement distinguishes between the treatment of tax matters for “joint” filings compared to “separate” and “unitary state” filings prior to the Separation. “Joint” filings are returns, such as the United States federal return, which include operations from both Former Parent legal entities and the Company. By contrast, “separate” filings are tax returns (primarily United States state returns and non-United States returns) that exclusively include either the Former Parent’s or the Company’s operations. “Unitary state” filings are state tax returns which may include legal entities of both the Company and the Former Parent. In accordance with the Tax Matters Agreement, the Company is liable for and has indemnified the Former Parent against all income tax liabilities involving “separate” and “unitary state” filings for periods prior to the Separation, except to the extent a unitary state filing includes a legal entity of the Former Parent and the adjustment relates to that legal entity. The Company is also liable for fifty percent of all cash taxes paid as a result of any adjustment or redetermination or otherwise in connection with any tax contest relating to any joint return. In connection with the Separation, the Company was required to enter into a transfer agreement under Section 965(h) and to become the primary obligor of the remaining installment payments associated with the Section 965 liability. The Former Parent is obligated under the Tax Matters Agreement for fifty percent of the installment obligation. Under the Separation Agreement, the Company is responsible for any tax indemnity related to the discontinued operations by the Former Parent. Income from continuing operations before income taxes and Income tax expense consisted of the following: Year Ended December 31, 2023 2022 2021 (In thousands) Income from continuing operations before income taxes: Domestic operations $ 37,364 $ (19,234) $ 10,140 Foreign operations 281,728 319,485 308,948 $ 319,092 $ 300,251 $ 319,088 Income tax expense: Current: Federal $ 18,034 $ 8,928 $ 18,477 State 3,760 2,451 1,797 Foreign 99,036 77,728 68,779 120,830 89,107 89,053 Deferred: Federal (11,897) (7,501) (12,700) State (1,341) 358 161 Foreign (11,865) (12,794) 3,895 (25,103) (19,937) (8,644) $ 95,727 $ 69,170 $ 80,409 The Company’s Income tax expense differs from the amount that would be computed by applying the United States federal statutory rate as follows: Year Ended December 31, 2023 2022 2021 (In thousands) Taxes calculated at the United States federal statutory rate $ 67,010 $ 63,053 $ 67,008 State taxes 1,630 2,809 1,933 Effect of tax rates on international operations 1,548 (9,010) (8,879) Changes in tax reserves 10,753 (350) 2,734 Non-taxable dividends — — (46) Research and development tax credits (714) (542) (587) Effect of United States taxation on international operations 1,527 310 (313) Permanent differences, net 10,077 7,209 483 Provision to return 703 (7,055) (7,415) Withholding taxes 11,172 12,133 9,567 Capital gain — (3,655) 12,371 Valuation Allowance (12,308) 4,503 3,737 Other 4,329 (235) (184) Income tax expense $ 95,727 $ 69,170 $ 80,409 For the year ended December 31, 2023, the Company’s effective rate differs from the United States federal statutory rate of 21% due to changes in tax reserves, permanent differences relating to foreign subsidiaries and withholding taxes, partially offset by the favorable impact from changes in valuation allowances. The Company’s effective tax rate for years ending December 31, 2022 and December 31, 2021 differed from the United States federal statutory rate of 21% due to the impact of withholding taxes and permanent differences relating to foreign subsidiaries, partially offset by the favorable impact from the Company’s earnings outside the United States taxed at different rates than the United States federal statutory rate. The change in tax reserves in 2023 is largely the result of an adverse court ruling in an unrelated taxpayer’s tax case in a foreign jurisdiction. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. All deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets. The temporary differences that gave rise to the significant components of deferred tax assets and liabilities are presented below: December 31, 2023 2022 (In thousands) Deferred tax assets: Post-retirement benefit obligation $ 1,350 $ 5,761 Expenses currently not deductible 52,526 36,320 Net operating loss carryforward 107,395 111,497 Tax credit carryforward 4,581 10,320 Depreciation and amortization 7,404 9,124 Inventory 12,238 5,685 Capitalized R&D Costs 18,178 14,160 Leases 23,987 22,713 Other 2,866 — Valuation allowance (79,354) (88,202) Deferred tax assets, net $ 151,171 $ 127,378 Deferred tax liabilities: Depreciation and amortization $ (120,055) $ (121,858) Leases (23,987) (22,713) Outside basis differences and other (79,985) (79,623) Total deferred tax liabilities $ (224,027) $ (224,194) Total deferred tax liabilities, net $ (72,856) $ (96,816) Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets on a net jurisdictional basis as follows: December 31, 2023 2022 (In thousands) Other assets $ 46,602 $ 42,860 Other liabilities (119,458) (139,676) Deferred tax liability, net $ (72,856) $ (96,816) The Company evaluates the recoverability of its deferred tax assets on a jurisdictional basis by considering whether deferred tax assets will be realized on a more likely than not basis. To the extent a portion or all of the applicable deferred tax assets do not meet the more likely than not threshold, a valuation allowance is recorded. During the year ended December 31, 2023, the valuation allowance decreased from $88.2 million to $79.4 million. with a net decrease of $12.3 million recognized as a decrease to Income tax expense, and a $3.4 million increase related to changes in foreign currency rates. The current year change primarily relates to the change in conclusion regarding the realizability of net operating loss carryforwards in a foreign jurisdiction. In determining how much of the relevant deferred tax asset could be realized on a more likely than not basis, consideration was given to tax planning strategies and, when applicable, future taxable income. The Company has United States federal net operating loss carryforwards of $11.6 million as of December 31, 2023 expiring in years 2028 through 2036. The Company’s ability to use these various carryforwards to offset any taxable income generated in future taxable periods may be limited under Section 382 and other federal tax provisions. As of December 31, 2023 the Company also has $414.6 million foreign net operating loss carryforwards primarily in the United Kingdom, Germany, the Netherlands and Sweden that may be subject to local tax restriction limitations. The foreign net operating losses can be carried forward indefinitely, except in applicable jurisdictions that make up less than five percent of the available net operating losses. As of December 31, 2023, the Company incurred $10.9 million of tax expense relating to a distribution of earnings for which it has changed its indefinite reinvestment assertion. Other than this expense incurred in the year ended December 31, 2023, the Company has not made any other material changes to its indefinite reinvestment assertion with respect to earnings reinvested in its foreign operations. The majority of our global unremitted foreign earnings have been taxed or would be exempt from United States tax upon repatriation. The Company has made no provision for United States income taxes or additional non-United States taxes on certain undistributed earnings or outside basis differences of non-United States subsidiaries in which the Company remains indefinitely reinvested. A portion of these undistributed earnings may be subject to foreign and United States tax consequences upon remittance. The Company cannot practically estimate the amount of additional taxes that might be payable on those undistributed earnings. The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). This liability for such uncertain tax positions includes the amount of benefit included in (i) its previously filed income tax returns and (ii) its financial results expected to be included in income tax returns to be filed for periods through the date of its Consolidated and Combined Financial Statements. The Company’s total unrecognized tax benefits were $30.9 million, $20.2 million and $37.7 million as of December 31, 2023, 2022 and 2021, respectively, inclusive of $12.1 million, $5.6 million and $6.2 million, respectively, of interest and penalties. The Company records interest and penalties on uncertain tax positions as a component of Income tax expense, which was an expense of $7.9 million, benefit of $0.7 million and expense of $0.9 million for the years ended December 31, 2023, 2022 and 2021, respectively. The change in the balance for the year ended December 31, 2023 is primarily due to the increase in liability for an adverse court ruling in an unrelated taxpayer’s tax case in a foreign jurisdiction. A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (inclusive of associated interest and penalties): (In thousands) Balance, January 1, 2021 $ 35,201 Addition for tax positions taken in prior periods 738 Addition for tax positions taken in the current period 2,987 Reductions related to settlements with taxing authorities (425) Reductions resulting from a lapse of applicable statute of limitations (565) Other, including the impact of foreign currency translation and United States tax rate changes (255) Balance, December 31, 2021 37,681 Addition for tax positions taken in prior periods 1,971 Addition for tax positions taken in the current period 1,171 Reductions related to settlements with taxing authorities (922) Transfer from Former Parent, impact of foreign currency translation and other (2,801) Other, including the impact of foreign currency translation and United States tax rate changes (16,897) Balance, December 31, 2022 20,203 Addition for tax positions taken in prior periods 13,514 Addition for tax positions taken in the current period — Reductions related to settlements with taxing authorities (4,160) Reductions resulting from a lapse of applicable statute of limitations (473) Other, including the impact of foreign currency translation 1,787 Balance, December 31, 2023 $ 30,871 The Company files numerous group and separate tax returns in Unites States federal and state jurisdictions, as well as international jurisdictions. The Company is routinely examined by various United States and non-United States taxing authorities. The Company is subject to audit by the United States, various states and foreign jurisdictions. In accordance with the Tax Matters Agreement with Former Parent, the Company is the primary obligor for (i) ESAB separate company state returns for all periods; (ii) unitary state returns that include only ESAB legal entities for all periods, and (iii) ESAB separate foreign returns for all periods. Pursuant to United States tax law, the Company filed its initial United States federal income tax return for the post-Separation period in October 2023. The Company reviews its global tax provisions on a quarterly basis. The Company accrues or adjusts contingent tax liabilities based on these reviews, the results of discussions and resolutions of matters with certain tax authorities, tax rulings and court decisions and the expiration of the statutes of limitations. Due to the difficulty in predicting with reasonable certainty when tax audits will be fully resolved and closed, the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next 12 months is difficult to ascertain. The Company does not believe the total amount of unrecognized benefits will change by a material amount within the next 12 months due to the settlement of audits and expirations of statutes of limitations.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
Goodwill and Intangible Assets	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table summarizes Goodwill activity by segment for the years ended December 31, 2023 and 2022: Americas EMEA & APAC Total (In thousands) Balance, January 1, 2022 $ 519,154 $ 1,013,839 $ 1,532,993 Goodwill attributable to acquisition 63,183 13,047 76,230 Impact of foreign currency translation 3,508 (82,964) (79,456) Balance, December 31, 2022 585,845 943,922 1,529,767 Goodwill attributable to acquisitions 1,664 13,912 15,576 Impact of foreign currency translation 2,366 40,622 42,988 Balance, December 31, 2023 $ 589,875 $ 998,456 $ 1,588,331 The following table summarizes the Company’s Intangible assets, excluding Goodwill: December 31, 2023 2022 Gross Accumulated Gross Accumulated (In thousands) Indefinite-Lived Intangible Assets Trade names $ 185,301 $ — $ 180,691 $ — Definite-Lived Intangible Assets Customer relationships 496,483 (231,848) 482,499 (203,041) Technology 73,288 (55,288) 71,192 (50,005) Trade names 23,966 (10,983) 22,464 (9,412) Software 80,203 (61,920) 94,904 (74,799) Other intangible assets 22,878 (22,545) 22,800 (20,126) $ 882,119 $ (382,584) $ 874,550 $ (357,383) Amortization expense related to intangible assets of $39.7 million , $35.6 million and $42.1 million for the years ended December 31, 2023, 2022 and 2021, respectively, are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. Expected Amortization Expense The Company’s expected annual amortization expense for acquired intangible assets for the next five years is as follows: December 31, 2023 (In thousands) 2024 $ 29,160 2025 28,115 2026 27,027 2027 22,562 2028 20,782

Property, Plant and Equipment,

Property, Plant and Equipment, Net	12 Months Ended
Property, Plant and Equipment, Net	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net	Property, Plant and Equipment, Net December 31, Depreciable Life 2023 2022 (In years) (In thousands) Land n/a $ 15,095 $ 15,839 Buildings and improvements 5-40 178,682 164,472 Machinery and equipment 3-15 394,318 382,830 588,095 563,141 Accumulated depreciation (293,790) (278,915) $ 294,305 $ 284,226 Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $30.0 million , $29.5 million and $32.5 million, respectively.

Inventories, Net

Inventories, Net	12 Months Ended
Inventories, Net	Dec. 31, 2023
Inventory Disclosure [Abstract]
Inventories, Net	Inventories, Net Inventories, net consisted of the following: December 31, 2023 2022 (In thousands) Raw materials $ 156,583 $ 153,099 Work in process 43,561 44,086 Finished goods 244,580 261,902 444,724 459,087 LIFO reserve (4,279) (2,168) Less: allowance for excess, slow-moving and obsolete inventory (47,587) (40,090) $ 392,858 $ 416,829 At December 31, 2023 and 2022, approximately 27.4% and 31.5% of total inventories, respectively, were valued using the LIFO method.

Leases

Leases	12 Months Ended
Leases	Dec. 31, 2023
Leases [Abstract]
Leases	Leases The Company leases certain office spaces, warehouses, production facilities, vehicles and equipment. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Most leases include renewal options, which can extend the lease term into the future. The Company determines the lease term by assuming options that are reasonably certain of being renewed will be exercised. Certain of the Company’s leases include rental payments adjusted for inflation. The right-of-use lease asset is recorded on the Consolidated Balance Sheets, with the current lease liability being included in Accrued liabilities and noncurrent lease liability being included in Other liabilities. Operating lease expense was $25.4 million, $21.3 million and $23.0 million for the years ended December 31, 2023, 2022 and 2021, respectively. December 31, 2023 (In thousands) Future lease payments by year: 2024 $ 25,769 2025 20,540 2026 14,366 2027 9,938 2028 8,645 Thereafter 32,190 Total 111,448 Less: present value discount (12,045) Present value of lease liabilities $ 99,403 Weighted-average remaining lease term (in years): Operating leases 6.62 Weighted-average discount rate: Operating leases 3.5 %

Accrued and Other Liabilities

Accrued and Other Liabilities	12 Months Ended
Accrued and Other Liabilities	Dec. 31, 2023
Accrued Liabilities [Abstract]
Accrued and Other Liabilities	Accrued and Other Liabilities Accrued and Other liabilities in the Consolidated Balance Sheets consisted of the following: December 31, 2023 December 31, 2022 Current Noncurrent Current Noncurrent (In thousands) Accrued taxes and deferred tax liabilities $ 45,681 $ 144,662 $ 49,615 $ 161,500 Compensation and related benefits 97,052 52,589 74,794 57,438 Asbestos liability 32,908 234,796 30,108 230,581 Contract liability 31,248 — 25,899 — Lease liability 22,794 76,609 18,664 76,163 Warranty liability 12,606 — 12,946 — Third-party commissions 18,711 — 18,315 — Restructuring liability 5,345 354 7,533 285 Other 47,144 33,823 47,436 19,372 $ 313,489 $ 542,833 $ 285,310 $ 545,339 Accrued Warranty Liability A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated Balance Sheets is as follows: Year Ended December 31, 2023 2022 (In thousands) Warranty liability, beginning of period $ 12,946 $ 14,954 Accrued warranty expense 5,794 5,322 Changes in estimates related to pre-existing warranties 3,097 2,821 Cost of warranty service work performed (10,710) (9,680) Acquisition-related liability 1,278 — Foreign exchange translation effect 201 (471) Warranty liability, end of period $ 12,606 $ 12,946 Accrued Restructuring Liability The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated Balance Sheets is as follows: Year Ended December 31, 2023 Balance at Beginning of Period Charges Payments Foreign Currency Translation Balance at End of Period (In thousands) Restructuring and other related charges: Termination benefits (1) $ 4,910 $ 10,017 $ (10,223) $ (109) $ 4,595 Facility closure costs and other (2) 2,908 8,637 (10,483) 42 1,104 Subtotal $ 7,818 18,654 $ (20,706) $ (67) $ 5,699 Non-cash charges (3) 5,456 Total $ 24,110 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines. (3) Includes impairment of long-lived assets in connection with the closure and optimization of facilities and product lines. Year Ended December 31, 2022 Balance at Beginning of Period Charges Payments Foreign Currency Translation Balance at End of Period (In thousands) Restructuring and other related charges: Termination benefits (1) $ 7,818 $ 4,642 $ (7,626) $ 76 $ 4,910 Facility closure costs (2) 291 17,656 (15,068) 29 2,908 Subtotal $ 8,109 22,298 $ (22,694) $ 105 $ 7,818 Non-cash charges (3) 798 Total $ 23,096 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines. (3) Includes impairment of long-lived assets in connection with the closure and optimization of facilities and product lines.

Benefit Plans

Benefit Plans	12 Months Ended
Benefit Plans	Dec. 31, 2023
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees. The Company uses December 31 st as the measurement date for all of its employee benefit plans. Prior to the Separation, the Former Parent offered both funded and unfunded noncontributory defined benefit pension plans in t he United States that were share d amongst its businesses, including the Company prior to the Company becoming plan sponsor. The participation of the Company’s employees and retirees in this plan was as though it participated in a multiemployer plan with the Former Parent. As a result, prior to the Separation, a proportionate share of the cost associated with this defined benefit plan was allocated to the Company based on the Company’s share of total Former Parent headcount. This allocation is reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations , while any assets and liabilities associated with this defined benefit plan were retained by the Former Parent and were not recorded on the Company’s historical Combined Financial Statements. As part of the Separation, certain United States defined benefit and other post-retirement plans, formerly sponsored by the Former Parent were transferred to the Company as of March 21, 2022 (“Transfer Date”). As of the Transfer Date, the transferred plans include a defined benefit pension plan with assets of $201.3 million and projected benefit liabilities of $200.7 million, one unfunded defined benefit plan with liabilities of less than $0.1 million and one other post-retirement benefit plan with liabilities of $11.7 million, all of which were recorded in the financial statements of the Former Parent at December 31, 2021. During the year ended December 31, 2022, the Company recognized a Pension settlement gain of $9.1 million related to a completed buy-out of a foreign defined benefit plan by a third party plus the merger of two Company pension plans resulting in one plan benefiting from the surplus assets in the other plan. During the year ended December 31, 2021, the Company recognized a Pension settlement gain of $11.2 million when the trustees of a Company pension plan agreed to merge the plan with another Company pension plan and contribute the plan’s surplus assets. These amounts are reflected in Pension settlement gain in the Consolidated and Combined Statements of Operations. The following table summarizes the total changes in the Company’s pension and accrued post-retirement benefits and plan assets and includes a statement of the plans’ funded status: Pension Benefits Other Post-Retirement Benefits Year Ended December 31, Year Ended December 31, 2023 2022 2023 2022 (In thousands) Change in benefit obligation: Projected benefit obligation, beginning of year $ 256,022 $ 142,914 $ 8,850 $ 382 Transfer from Former Parent — 200,690 — 11,697 Service cost 1,439 1,684 11 15 Interest cost 11,170 5,874 393 234 Plan amendments 175 862 — — Actuarial loss (gain) 802 (60,148) (514) (2,807) Foreign exchange effect 4,079 (12,452) (1) (35) Benefits paid (27,720) (23,385) (549) (636) Settlements (3,584) (283) — — Other 360 266 — — Projected benefit obligation, end of year $ 242,743 $ 256,022 $ 8,190 $ 8,850 Accumulated benefit obligation, end of year $ 239,578 $ 253,123 $ 8,190 $ 8,850 Change in plan assets: Fair value of plan assets, beginning of year $ 219,050 $ 84,503 $ — $ — Transfer from Former Parent — 201,259 — — Actual return on plan assets 19,651 (51,266) — — Employer contributions (1) (857) 5,315 549 636 Foreign exchange effect 3,162 (7,583) — — Benefits paid (27,720) (23,385) (549) (636) Settlements (2,505) 9,947 — — Other 691 260 — — Fair value of plan assets, end of year $ 211,472 $ 219,050 $ — $ — Funded status, end of year $ (31,271) $ (36,972) $ (8,190) $ (8,850) Amounts recognized on the Consolidated Balance Sheets as of December 31: Non-current assets $ 17,300 $ 15,701 $ — $ — Current liabilities (3,186) (3,025) (764) (824) Non-current liabilities (45,385) (49,648) (7,426) (8,026) Total $ (31,271) $ (36,972) $ (8,190) $ (8,850) (1) The employer contribution amount for the year ended December 31, 2023 includes a refund of assets totaling $5.1 million to the Company arising from a completed wind up of a foreign defined benefit plan. For pension plans with accumulated benefit obligations in excess of plan assets, the accumulated benefit obligation and fair value of plan assets were $50.7 million and $3.9 million, respectively, as of December 31, 2023 and $201.1 million and $149.8 million, respectively, as of December 31, 2022. For pension plans with projected benefit obligations in excess of plan assets, the projected benefit obligation and fair value of plan assets were $55.6 million and $7.0 million, respectively, as of December 31, 2023 and $206.8 million and $154.1 million, respectively, as of December 31, 2022. The following table summarizes the changes in the Company’s foreign pension benefit obligations and plan assets, included in the table above, and includes a statement of the plans’ funded status: Foreign Pension Benefits Year Ended December 31, 2023 2022 (In thousands) Change in benefit obligation: Projected benefit obligation, beginning of year $ 99,401 $ 141,278 Service cost 1,439 1,684 Interest cost 4,148 2,161 Plan amendments 175 862 Actuarial loss (gain) 335 (25,131) Foreign exchange effect 4,079 (12,452) Benefits paid (7,138) (8,984) Settlements (3,584) (283) Other 360 266 Projected benefit obligation, end of year $ 99,215 $ 99,401 Accumulated benefit obligation, end of year $ 96,049 $ 96,500 Change in plan assets: Fair value of plan assets, beginning of year $ 70,821 $ 84,503 Actual return on plan assets 1,262 (12,494) Employer contributions (1,015) 5,170 Foreign exchange effect 3,162 (7,581) Benefits paid (7,138) (8,984) Settlements (2,505) 9,947 Other 691 260 Fair value of plan assets, end of year $ 65,278 $ 70,821 Funded status, end of year $ (33,937) $ (28,580) Expected contributions to the Company’s pension and other post-employment benefit plans for the year ending December 31, 2024 are $5.2 million. The following benefit payments are expected to be paid during each respective fiscal year: Pension Benefits Other Post-Retirement Benefits All Plans Foreign Plans (In thousands) 2024 $ 21,183 $ 7,256 $ 764 2025 20,635 7,074 745 2026 20,300 7,138 744 2027 19,912 7,175 740 2028 19,134 6,802 688 2029 - 2033 89,736 35,683 3,055 The Company’s primary investment objective for its pension plan assets is to provide a source of retirement income for the plans’ participants and beneficiaries. The assets are invested with the goal of preserving principal while providing a reasonable rate of return over the long term. Diversification of assets is achieved through strategic allocations to various asset classes. Actual allocations to each asset class vary due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced as required, as frequently as on a quarterly basis in some instances. The target allocation for plan assets varies by plan and jurisdiction. The actual allocation percentages as of December 31, 2023 and 2022 are consistent with the target allocation ranges of the plans. The following are the actual allocation percentages for the Company’s pension plan assets: Actual Asset Allocation December 31, 2023 2022 United States Plans: Equity securities: United States 38 % 36 % International 12 % 13 % Fixed income 49 % 50 % Cash and cash equivalents 1 % 1 % Foreign Plans: Equity securities 1 % 4 % Fixed income securities 48 % 34 % Cash and cash equivalents 1 % 16 % Insurance contracts 38 % 34 % Investment funds (1) 12 % 12 % (1) Represents various fixed income and equity securities. A summary of the Company’s pension plan assets for each fair value hierarchy level for the periods presented follows (see Note 17, “Fai r Value Measurements” for further description of the levels within the fair value hierarchy): December 31, 2023 Measured at Net Asset Value (1) Level Level Level (In thousands) United States Plans: Cash and cash equivalents $ — $ 1,237 $ — $ — $ 1,237 Equity securities: United States large cap 29,289 — — — 29,289 United States small/mid cap 10,130 16,033 — — 26,163 International 18,078 — — — 18,078 Fixed income mutual funds: United States government and corporate 70,283 — — — 70,283 Other — 1,145 — — 1,145 Foreign Plans: Cash and cash equivalents (2) — 547 — — 547 Equity securities — 921 — — 921 Non-United States government and corporate bonds — 31,147 — — 31,147 Insurance contracts — — 24,592 — 24,592 Investment funds — — 8,050 — 8,050 Other — — 20 — 20 $ 127,780 $ 51,030 $ 32,662 $ — $ 211,472 (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, which are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term. (2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets. December 31, 2022 Measured at Net Asset Value (1) Level Level Level (In thousands) United States Plans: Cash and cash equivalents $ — $ 1,591 $ — $ — $ 1,591 Equity securities: United States large cap 31,018 — — — 31,018 United States small/mid cap 10,789 11,289 — — 22,078 International 18,928 — — — 18,928 Fixed income mutual funds: United States government and corporate 73,497 — — — 73,497 Other — 1,118 — — 1,118 Foreign Plans: Cash and cash equivalents (2) — 11,348 — — 11,348 Equity securities — 2,475 — — 2,475 Non-United States government and corporate bonds — 24,289 — — 24,289 Insurance contracts — — 24,236 — 24,236 Investment funds — — 8,400 — 8,400 Other — 33 39 — 72 $ 134,232 $ 52,143 $ 32,675 $ — $ 219,050 (1) Certain investments that are measured at fair value using the NAV have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, which are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term. (2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets. The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans: Pension Benefits Other Post-Retirement Benefits Year Ended December 31, Year Ended December 31, 2023 2022 2021 2023 2022 2021 (In thousands) Components of Net Periodic Benefit (Income) Cost: Service cost $ 1,439 $ 1,684 $ 1,785 $ 11 $ 15 $ 14 Interest cost 11,170 5,874 1,668 393 234 22 Amortization 1,206 4,313 1,220 — (181) — Settlement (gain) loss — (9,114) (11,195) — — 8 Other — 92 2 — — — Expected return on plan assets (11,391) (11,519) (2,258) — — — Net periodic benefit cost (income) $ 2,424 $ (8,670) $ (8,778) $ 404 $ 68 $ 44 Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Transfer from Former Parent $ — $ 53,134 $ — $ — $ (2,629) $ — Current year net actuarial (gain) loss (7,021) 949 (5,788) (514) (2,807) (27) Current year prior service cost 175 862 — — — — Less amounts included in net periodic benefit cost: Amortization of net (loss) gain (1,575) (4,340) (1,228) 479 181 (8) Settlement/divestiture/other loss (1,079) (67) — — — — Amortization of prior service cost 38 (1,067) (5) — — — Total recognized in Other comprehensive (gain) loss $ (9,462) $ 49,471 $ (7,021) $ (35) $ (5,255) $ (35) Each component of net periodic benefit (income) cost is included in the Company’s Consolidated and Combined Statements of Operations for the years ended December 31, 2023, 2022 and 2021. Service cost is included within Selling, general and administrative expense with the non-service costs net of expected return on plan assets and settlement gains included within Interest expense (income) and other, net. Settlement gains of $9.1 million and $11.2 million are recorded within Pension settlement gain on the Company’s Consolidated and Combined Statement of Operations for the years ended December 31, 2022 and 2021, respectively. The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above: Foreign Pension Benefits Year Ended December 31, 2023 2022 2021 (In thousands) Components of Net Periodic Benefit (Income) Cost: Service cost $ 1,439 $ 1,684 $ 1,785 Interest cost 4,148 2,161 1,646 Amortization 40 687 1,118 Settlement gain — (9,114) (11,195) Other (331) 92 2 Expected return on plan assets (2,475) (2,063) (2,258) Net periodic benefit cost (income) $ 2,821 $ (6,553) $ (8,902) Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Current year net actuarial loss (gain) $ 1,984 $ (12,262) $ (5,710) Current year prior service cost 175 862 — Less amounts included in net periodic benefit (income) cost: Amortization of net loss (78) (714) (1,126) Settlement/divestiture/other loss (1,079) (67) — Amortization of prior service cost 38 (1,067) (5) Total recognized in Other comprehensive loss (gain) $ 1,040 $ (13,248) $ (6,841) The components of net unrecognized pension and other post-retirement benefit cost included in Accumulated other comprehensive loss in the Consolidated Balance Sheets that have not been recognized as a component of net periodic benefit cost are as follows: Pension Benefits Other Post-Retirement December 31, December 31, 2023 2022 2023 2022 (In thousands) Net actuarial loss (gain) $ 61,573 $ 71,066 $ (5,234) $ (5,199) Prior service income (81) (112) — — Total $ 61,492 $ 70,954 $ (5,234) $ (5,199) The key economic assumptions used in the measurement of the Company’s pension and other post-retirement benefit obligations are as follows: Pension Benefits Other Post-Retirement December 31, December 31, 2023 2022 2023 2022 Weighted-average discount rate: All plans 4.4 % 4.6 % 4.8 % 5.0 % Foreign plans 3.9 % 4.3 % — % — % Weighted-average rate of increase in compensation levels for active foreign plans (1) 3.1 % 3.2 % — % — % (1) Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. The key economic assumptions used in the computation of net periodic benefit cost are as follows: Pension Benefits Other Post-Retirement Benefits Year Ended December 31, Year Ended December 31, 2023 2022 2021 2023 2022 2021 Weighted-average discount rate: All plans 4.6 % 2.2 % 1.3 % — % 2.6 % 6.0 % Foreign plans 4.3 % 1.9 % 1.3 % — % — % — % Weighted-average expected return on plan assets: All plans 5.0 % 4.8 % 3.6 % — % — % — % Foreign plans 4.1 % 3.2 % 3.6 % — % — % — % Weighted-average rate of increase in compensation levels for active foreign plans (1) 3.2 % 3.2 % 3.4 % — % — % — % (1) Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. In determining discount rates, the Company utilizes the single discount rate equivalent to discounting the expected future cash flows from each plan using the yields at each duration from a published yield curve as of the measurement date. For measurement purposes, a weighted-average annual rate of increase in the per capita cost of covered health care benefits of 7.5% was assumed. The rate was assumed to decrease gradually to 4.0% by 2034 and remain at that level thereafter for benefits covered under the plans. The expected long-term rate of return on plan assets is determined using the calculated value of plan assets, which is based on the Company’s investment policy target allocation of the asset portfolio between various asset classes and the expected real returns of each asset class over various periods of time that are consistent with the long-term nature of the underlying obligations of these plans. The Company maintains defined contribution plans covering certain union and non-union employees. The Company’s expense for the years ended December 31, 2023, 2022 and 2021 was $7.6 million, $8.7 million and $7.9 million, respectively.

Debt

Debt	12 Months Ended
Debt	Dec. 31, 2023
Debt Disclosure [Abstract]
Debt	Debt Long-term debt consists of the following: December 31, 2023 2022 (In thousands) Term loans $ 987,500 $ 1,000,000 Revolving credit facilities 32,000 221,000 Total debt 1,019,500 1,221,000 Unamortized deferred financing fees (1,443) (2,357) Long-term debt $ 1,018,057 $ 1,218,643 Term Loans and Revolving Credit Facility On April 4, 2022, the Company entered into a credit agreement (as amended and restated from time-to-time, the “Credit Agreement”) in connection with the Separation. The Credit Agreement initially consisted of the following facilities: • a $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027; • a Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and • a $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023. The Revolving Facility contains a $300 million foreign currency sublimit and a $50 million swing line loan sub-facility. On April 4, 2022, the Company drew down $1.2 billion available under the credit facilities made up of (i) $200 million under the Revolving Facility, (ii) $400 million under the Term Loan A-1 Facility and (iii) $600 million under the Term Loan A-2 Facility. The Company used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation. On June 28, 2022, the Company amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million term loan facility (the “Term Loan A-3 Facility” and, together with the Term Loan A-1 Facility, the “Term Facilities,” and, together with the Revolving Facility, the “Facilities”) with a maturity date of April 3, 2025 to refinance the Company’s existing Term Loan A-2 Facility. Also on June 28, 2022, the Company borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility. As of December 31, 2023, the Credit Agreement consists of the following facilities: • A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027; • A Term A-1 loan with an aggregate principal amount of $395 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and, • A Term Loan A-3 loan with an aggregate principal amount of $593 million (the “Term Loan A-3 Facility”) with a maturity date of April 3, 2025. The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Agreement requires that the Company maintains certain financial covenants and the Company was in compliance with all of its debt covenants as of December 31, 2023. The Credit Agreement contains various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Facilities and the Revolving Facility. Certain United States subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement. Loans made under the Term Facilities will bear interest, at the election of the Company, at either the base rate (as defined in the Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) plus an adjustment (as defined in the Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in dollars, the term SOFR plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in Euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) and, (iii) in the case of loans denominated in sterling, Sterling Overnight Index Average (“SONIA”) plus an adjustment (as all such rates are defined in the Credit Agreement Amendment), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin. To manage exposures to currency exchange rates and interest rates arising in Long term debt, the Company entered into interest rate and cross currency swap agreements during the year ended December 31, 2022. Refer to Note 16, “Derivatives” for additional information. As of December 31, 2023, the weighted-average interest rate of borrowings under the Credit Agreement was 5.223%, including the net impact from the interest rate and cross currency swaps and excluding accretion of deferred financing fees, and there was $718 million of borrowing capacity available on the Revolving Facility. Other Indebtedness In addition to the debt agreements discussed above, the Company also has the ability to inc ur approxi mately $78 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company currently has in place that the Company has used from time to time in the past for short-term working capital needs. The Company is party to letter of credit facilities with an aggregate capacity of $109.0 million. Total letters of credit of $28.6 million were outstanding as of December 31, 2023. Deferred Financing Fees In total, the Company had deferred financing fees of $2.3 million included in its Consolidated Balance Sheet as of December 31, 2023, which will be charged to Interest expense (income) and other, net, using the straight-line method. The costs associated with the Term Facilities will be amortized over the contractual term of the Term Facilities and the costs associated with the Revolving Facility will be amortized over the life of the Credit Agreement. Of the $2.3 million, $0.9 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $1.4 million of deferred financing fees relating to the Term Facilities are recorded as a contra-liability within Long-ter m debt. Other The Company’s minimum principal payments for the next five years are as follows: December 31, 2023 (in thousands) 2024 $ — 2025 592,500 2026 — 2027 427,000 2028 — Total debt (1) $ 1,019,500 (1) Total debt excludes $1.4 million of related unamortized deferred financing fees.

Derivatives

Derivatives	12 Months Ended
Derivatives	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable. The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of December 31, 2023. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated Balance Sheets at fair value. Cash Flow Hedges On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts is $600 million and they mature in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company. The spread is 1.250% as of December 31, 2023. These agreements involve the receipt of floating-rate amounts in exchange for fixed-rate interest payments over the life of the agreement without an exchange of the underlying principal amount. The above interest rate swap agreements are designated and qualify as a cash flow hedge, and as such the gain or loss on the derivative instrument due to the change in fair value is reported as a component of AOCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. The Company did not have any ineffectiveness related to cash flow hedges during the year ended December 31, 2023. The cash inflows and outflows associated with the Company’s interest rate swap agreements designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated and Combined Statements of Cash Flows. The Company expects a gain o f $6.7 million, net of tax, related to interest rate swap agreements to be reclassified from AOCI to earnings over the next 12 months as the hedged transactions are realized. The expected gain to be reclassified is based on current forward rates in active markets as of December 31, 2023. The effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following: Year Ended December 31, Derivative type (Gain) loss recognized in the Consolidated and Combined Statements of Operations: 2023 2022 (In thousands) Interest rate swap agreements Interest expense (income) and other, net $ (11,053) $ 413 Net Investment Hedges On July 22, 2022, the Company entered into two cross-currency swap agreements to partially hedge its net investment in its Euro denominated subsidiaries against adverse movements in exchange rates between the U.S. dollar and the Euro. In addition, the cross-currency swap agreements include provisions to exchange fixed-rate payments in U.S. dollar for fixed-rate payments in Euro and are designated and qualify as a net investment hedge. These contracts have a Euro aggregate notional amount of approximately €270 million and a U.S. dollar aggregate notional amount of $275 million at December 31, 2023, and they mature in April 2025. The changes in the spot rate of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense (income) and other, net line item in the Consolidated and Combined Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The Company did not have any ineffectiveness related to net investment hedges during the year ended December 31, 2023. The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated and Combined Statements of Cash Flows. The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following: Year Ended December 31, Derivative type Gain recognized in the Consolidated and Combined Statements of Operations: 2023 2022 Cross currency swap agreements Interest expense (income) and other, net $ (4,779) $ (2,181) The table below shows the fair value of the derivatives recognized in the Company’s Consolidated Balance Sheets: December 31, 2023 December 31, 2022 Designated as hedging instruments Other Liabilities Other Assets Other Liabilities Other Assets (In thousands) Cross currency swap agreements $ 22,232 $ — $ 10,769 $ — Interest rate swap agreements — 9,522 — 14,342 Total $ 22,232 $ 9,522 $ 10,769 $ 14,342 Derivatives Not Designated as Hedging Instruments The Company has certain foreign currency contracts that are not designated as hedges. As of December 31, 2023 and December 31, 2022, the Company had foreign currency contracts related to purchases and sales with notional values of $232.5 million and $260.0 million, respectively. The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Company’s Consolidated Balance Sheets: December 31, 2023 December 31, 2022 Not designated as hedging instruments Accrued Liabilities Other Current Assets Accrued Liabilities Other Current Assets (In thousands) Foreign currency contracts $ 596 $ 1,088 $ 2,166 $ 3,682 The amounts in the table above as of December 31, 2023 reflect the fair value of the Company’s foreign currency contracts on a net basis where allowable under master netting agreements. Had these amounts been recognized on a gross basis, the impact would have been a $1.2 million increase in Other current assets with a corresponding increase in Accrued liabilities. The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship: Year Ended December 31, Foreign currency contracts 2023 2022 2021 (In thousands) Change in unrealized (loss) gain (1,023) 1,338 177 Realized loss (1) (2,928) (17,601) (5,631) (1) The year ended December 31, 2022 includes realized losses relating to certain corporate entities contributed to ESAB Corporation which are reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations. These realized losses are offset by unrealized gains which are also reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company utilizes fair value measurement guidance prescribed by accounting standards to value its financial instruments. The guidance establishes a fair value hierarchy based on the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows: Level One: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets. Level Two: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level Three: Inputs to the valuation methodology are unobservable and significant to the fair value measurement. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future. A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows (see Note 14, “Benefit Plan s” for classification of the assets of the Company’s benefit plans within the fair value hierarchy): December 31, 2023 Level Level Level Total (In thousands) Assets: Cash equivalents $ 6,027 $ — $ — $ 6,027 Foreign currency contracts - not designated as hedges — 2,261 — 2,261 Interest rate swap agreements — 9,522 — 9,522 Deferred compensation plans — 3,488 — 3,488 $ 6,027 $ 15,271 $ — $ 21,298 Liabilities: Foreign currency contracts - not designated as hedges $ — $ 1,769 $ — $ 1,769 Cross currency swap agreements — 22,232 — 22,232 Deferred compensation plans — 3,488 — 3,488 $ — $ 27,489 $ — $ 27,489 December 31, 2022 Level Level Level Total (In thousands) Assets: Cash equivalents $ 8,195 $ — $ — $ 8,195 Foreign currency contracts - not designated as hedges — 3,682 — 3,682 Interest rate swap agreements — 14,342 — 14,342 Deferred compensation plans — 2,501 — 2,501 $ 8,195 $ 20,525 $ — $ 28,720 Liabilities: Foreign currency contracts - not designated as hedges $ — $ 2,166 $ — $ 2,166 Cross currency swap agreements — 10,769 — 10,769 Deferred compensation plans — 2,501 — 2,501 $ — $ 15,436 $ — $ 15,436 The Company’s cash equivalents consist of investments in foreign interest-bearing deposit accounts and foreign money market mutual funds that are valued based on quoted market prices. The fair value of these investments approximate cost due to their short-term maturities and the high credit quality of the issuers of the underlying securities. The Company measures the fair value of foreign currency contracts, cross currency swap agreements and interest rate swap agreements using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the year ended December 31, 2023, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 16, “Derivatives” for additional information. There were no transfers in or out of Level One, Two or Three during the years ended December 31, 2023 and 2022. Concentration of Credit Risk Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable. Concentrations of credit risk are considered to exist when there are amounts collectible from multiple counterparties with similar characteristics, which could cause their ability to meet contractual obligations to be similarly impacted by economic or other conditions. The Company performs credit evaluations of its customers prior to delivery or commencement of services and normally does not require collateral. Letters of credit are occasionally required when the Company deems n ecessary. There are no customers which represent more than 10% of the Company’s Accounts receivable, net as of December 31, 2023 and 2022.

Equity

Equity	12 Months Ended
Equity	Dec. 31, 2023
Equity [Abstract]
Equity	Equity Accumulated Other Comprehensive Loss The following table presents the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the years ended December 31, 2023, 2022 and 2021. All amounts are net of tax and noncontrolling interest, if any. Accumulated Other Comprehensive Loss Components Net Unrecognized Pension and Other Post-Retirement Benefit Cost Foreign Currency Translation Adjustment Net Investment Hedges Cash Flow Hedges Total (In thousands) Balance at January 1, 2021 $ (29,378) $ (366,825) $ — $ — $ (396,203) Other comprehensive income (loss) before reclassifications: $ — Net actuarial gain 7,479 — — — 7,479 Foreign currency translation adjustment 1,534 (72,867) — — (71,333) Other comprehensive (loss) income before reclassifications 9,013 (72,867) — — (63,854) Amounts reclassified from Accumulated other comprehensive loss (1) (831) — — — (831) Net current period Other comprehensive (loss) income 8,182 (72,867) — — (64,685) Balance at December 31, 2021 (21,196) (439,692) — — (460,888) Other comprehensive income (loss) before reclassifications: Amounts contributed by Former Parent (2) (50,504) (8,759) — — (59,263) Net actuarial gain 113 — — — 113 Foreign currency translation adjustment 1,712 (82,351) (8,336) — (88,975) Loss on long-term intra-entity foreign currency transactions — (83,105) — — (83,105) Unrealized gain on cash flow hedges — — — 10,782 10,782 Other comprehensive (loss) income before reclassifications (48,679) (174,215) (8,336) 10,782 (220,448) Amounts reclassified from Accumulated other comprehensive loss (1) 6,028 — — 320 6,348 Net current period Other comprehensive (loss) income (42,651) (174,215) (8,336) 11,102 (214,100) Balance at December 31, 2022 (63,847) (613,907) (8,336) 11,102 (674,988) Other comprehensive income (loss) before reclassifications: Net actuarial gain 8,969 — — — 8,969 Foreign currency translation adjustment (3,285) (11,143) (8,879) — (23,307) Gain on long-term intra-entity foreign currency transactions — 70,428 — — 70,428 Unrealized gain on cash flow hedges — — — 4,834 4,834 Other comprehensive (loss) income before reclassifications 5,684 59,285 (8,879) 4,834 60,924 Amounts reclassified from Accumulated other comprehensive loss (1)(3) (1,642) — — (8,566) (10,208) Net current period Other comprehensive (loss) income 4,042 59,285 (8,879) (3,732) 50,716 Balance at December 31, 2023 $ (59,805) $ (554,622) $ (17,215) $ 7,370 $ (624,272) (1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14, “Benefit Plans” for additional details. (2) Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities which were part of the Corporate segment of the Former Parent and were transferred to ESAB Corporation in anticipation of the Separation. (3) During the years ended December 31, 2023 and 2022, the amount on this line within the Cash Flow Hedges column is a component of Interest expense (income) and other, net. See Note 16, “Derivatives,” for additional details. Share-Based Payments Prior to the Separation, the Company had no stock-based compensation plans; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans which provided for the grants of stock options and restricted stock units (“RSUs”). Prior to the Separation, the Former Parent allocated stock-based compensation expense to the Company based on ESAB employees participating in Former Parent plans. This is reflected in the accompanying Consolidated and Combined Statements of Operations and Comprehensive Income for the period prior to the Separation. Prior to the Separation, in addition to stock compensation expense related to direct employees of the Company, stock compensation expense related to certain corporate employees of the Former Parent was allocated to the Company based on the Company’s proportional share of total Former Parent revenues. For the three months ended April 1, 2022, $0.7 million of stock-based compensation expense was allocated to the Company. For the year ended December 31, 2021, $2.6 million was allocated to the Company. Following the Separation, the Company independently incurs stock compensation expenses as a stand-alone company. In connection with the Separation, the Company adopted the 2022 Omnibus Incentive Plan (the “Stock Plan”) that became effective upon the Separation. Outstanding equity awards of the Former Parent held by ESAB employees at the Separation date were converted into or replaced with awards of ESAB common stock under the Stock Plan, with the intent to maintain the economic value of the equity awards immediately before and after the Distribution. The terms of the equity awards period, exercisability and vesting schedule, as applicable, generally continued unchanged. Other than converted or replacement equity awards of ESAB issued in replacement of the Former Parent’s RSUs and stock options, the terms of the converted or replacement equity awards of ESAB (e.g. vesting date and expiration date) continued unchanged. The Company measures and recognizes compensation expense related to share-based payments based on the fair value of the instruments issued. Stock-based compensation expense is generally recognized as a component of Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. Stock Options Under the Stock Plan, the Company may grant options to purchase common stock, with a maximum term of 10 years at a purchase price equal to the market value of the Company’s common stock on the date of grant. Stock-based compensation expense for stock option awards is based upon the grant-date fair value using the Black-Scholes option pricing model. The Company recognizes compensation expense for stock option awards on a straight-line basis over the requisite service period of the entire award. For the year ended December 31, 2023, the Stock-based compensation expense for the stock option awards was $2.2 million. As of December 31, 2023 , the Company had $2.3 million of unrecognized compensation expense related to stock option awards that will be recognized over a weighted-average period of 1.9 years. Restricted Stock Units During the year ended December 31, 2023 and 2022, the Company granted certain employees performance-based restricted stock units (“PRSUs”), the vesting of which is fully based on company specific performance metrics over a three-year performance period. The awards also have a service requirement that equals the respective performance periods. These PRSUs are valued at the market value of a share of common stock on the date of grant taking into consideration the probability of achieving the specified performance goal. The ultimate payout of PRSUs with a performance metric adjusts the cumulative expense based on its estimate and the percent of the requisite service period that has elapsed. For the year ended December 31, 2023, the Stock-based compensation expense for the PRSU’s was $3.1 million. Under the Stock Plan, the Compensation Committee may also award RSUs to select executives, employees and outside directors, which typically vest over three years after the date of grant. With limited exceptions, the employee must remain in service until the vesting date. The Compensation Committee determines the terms and conditions of each award, including any restriction period and other criteria applicable to the awards. For the year ended December 31, 2023, the Stock-based compensation expense for the RSU’s was $9.8 million. The activity of the Company’s PRSUs and RSUs is as follows: PRSUs RSUs Number Weighted- Number Weighted- Balance at December 31, 2022 110,288 $ 53.99 464,278 $ 50.80 Granted 83,873 61.32 183,605 61.46 Vested (19,062) 59.42 (152,907) 51.00 Forfeited and expired (6,124) 61.32 (55,346) 53.52 Balance at December 31, 2023 168,975 56.75 439,630 54.84 The fair value of shares vested during the year ended December 31, 2023 was $8.9 million . As of December 31, 2023 , the Company had $18.4 million of unrecognized compensation expense related to PRSU and RSU awards that will be recognized over a weighted-average period of 2.0 years.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Asbestos Contingencies Certain entities that became subsidiaries of ESAB Corporation in connection with the Separation are the legal obligor for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from the Former Parent’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages. These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers and were not manufactured by any of the Company’s, or Former Parent’s, subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the United States Navy. The subs idiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years while the number of cases has steadily declined. The Company expects such fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment. The Company has classified asbestos-related activity in Loss from discontinued operations in the Consolidated and Combined Statements of Operations. This is consistent with the Former Parent’s classification on the basis that, pursuant to the purchase agreement from the Former Parent’s Fluid Handling business divestiture, the Former Parent retained its asbestos-related contingencies and insurance coverages. However, as the Former Parent did not retain an interest in the ongoing operations of the business subject to the contingencies, asbestos-related activity was classified as part of Loss from discontinued operations, net of taxes in the Consolidated Statements of Operations of the Former Parent. The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. Consistent with the Former Parent, it is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate. The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs that may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred. Each subsidiary has separate insurance coverage acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies and law pertaining to the affected subsidiary’s insurance policies. Asbestos-related claims activity since December 31, 2022 and 2021, respectively, is as follows: Year Ended December 31, 2023 2022 (Number of claims) Claims unresolved, beginning of period 14,106 14,559 Claims filed (1) 4,627 4,338 Claims resolved (2) (5,085) (4,791) Claims unresolved, end of period 13,648 14,106 (In dollars) Average cost of resolved claims (3) $ 9,524 $ 10,017 (1) Claims filed include all asbestos claims for which notification has been received or a file has been opened. (2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants. (3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries. The Company’s Consolidated Balance Sheets include the following amounts related to asbestos-related litigation: December 31, 2023 2022 (In thousands) Long-term asbestos insurance asset (1) $ 221,489 $ 215,112 Long-term asbestos insurance receivable (1) 17,868 17,231 Accrued asbestos liability (2) 32,908 30,108 Long-term asbestos liability (3) 234,796 230,581 (1) Included in Other assets in the Consolidated Balance Sheets. (2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets. (3) Included in Other liabilities in the Consolidated Balance Sheets. Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect the Company’s financial condition, results of operations or cash flow. General Litigation The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings is expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the proceeding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company. Off-Balance Sheet Arrangements As of December 31, 2023, the Company had $131.8 million of unconditional purchase obligations with suppliers, the majority of which is expected to be paid by December 31, 2024.

Segment Information

Segment Information	12 Months Ended
Segment Information	Dec. 31, 2023
Segment Reporting [Abstract]
Segment Information	Segment Information ESAB is a world leader in fabrication and gas control technology, providing our partners with fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions, which enable the everyday and extraordinary work that shapes our world. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and Adjusted EBITDA, which represents Net income from continuing operations excluding the impact of Income tax expense, Interest expense and other, net Pension settlement gain, Restructuring and other related charges, Separation costs, Acquisition - amortization and other related charges and Depreciation and other amortization . The Company’s segment results were as follows: Year Ended December 31, 2023 2022 2021 (In thousands) Net sales (1) : Americas $ 1,214,998 $ 1,128,306 $ 1,004,208 EMEA & APAC 1,559,768 1,465,174 1,423,907 $ 2,774,766 $ 2,593,480 $ 2,428,115 Adjusted EBITDA (2) : Americas $ 224,742 $ 188,577 $ 159,623 EMEA & APAC 276,360 248,177 244,458 $ 501,102 $ 436,754 $ 404,081 Depreciation, amortization and other impairment charges: Americas $ 34,589 $ 29,281 $ 33,890 EMEA & APAC 40,445 36,697 42,009 $ 75,034 $ 65,978 $ 75,899 Capital expenditures: Americas $ 21,576 $ 18,005 $ 14,095 EMEA & APAC 26,602 22,238 21,489 $ 48,178 $ 40,243 $ 35,584 (1) For the years ended December 31, 2023, 2022 and 2021, the total Net sales originating from the United States were $619.1 million, $583.0 million and $533.5 million, respectively. The remainder of the sales were derived from foreign countries. (2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA: Year Ended December 31, 2023 2022 2021 (In thousands) Net income from continuing operations $ 223,365 $ 231,081 $ 238,679 Income tax expense 95,727 69,170 80,409 Interest expense (income) and other, net (1) 85,074 37,950 (29) Pension settlement gain — (9,136) (11,208) Restructuring and other related charges (2) 24,110 23,096 18,954 Separation costs (3) — 15,545 2,865 Acquisition - amortization and other related charges (4) 36,851 34,196 35,949 Depreciation and other amortization 35,975 34,852 38,462 Adjusted EBITDA $ 501,102 $ 436,754 $ 404,081 (1) Relates to removal of interest expense, net included within the Interest expense (income) and other, net line within the Consolidated and Combined Statements of Operations. (2) I ncludes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expense, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines . (3) I ncludes non-recurrin g charges and employee costs related to the planning and execution of t he separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations. (4) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses. December 31, 2023 2022 (In thousands) Investments in Equity Method Investees: Americas $ — $ — EMEA & APAC 30,633 28,527 $ 30,633 $ 28,527 Total Assets: Americas $ 1,671,634 $ 1,666,799 EMEA & APAC 2,156,995 2,087,216 $ 3,828,629 $ 3,754,015 December 31, 2023 2022 (In thousands) Property, Plant and Equipment, Net (1) : United States $ 68,398 $ 68,380 Czech Republic 60,948 60,278 India 31,258 34,892 Russia 15,550 19,111 Mexico 23,922 17,666 Other foreign countries 94,229 83,899 $ 294,305 $ 284,226 (1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Related Party Agreements On April 4, 2022, in connection with the Separation, the Company entered into several agreements with Enovis that govern the Separation and provide a framework for the relationship between the parties going forward including a separation and distribution agreement, a transition services agreement, tax matters agreement, employee matters agreements, a stockholders and registration rights agreement, an intellectual property matters agreement and a license agreement for EBX. The Separation and Distribution Agreement The Company entered into a separation and distribution agreement (the “Separation Agreement”) with Enovis immediately prior to the distribution of the Company’s common stock to Enovis stockholders. The Separation Agreement sets forth the Company’s agreements with Enovis regarding the principal actions to be taken in connection with the Separation. The Separation Agreement contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of ESAB and Enovis as part of the Separation, (ii) cash distribution made to Enovis in partial consideration of the transfer of ESAB Assets to the Company in connection with the Separation and (iii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of ESAB’s business with ESAB and financial responsibility for the obligations and liabilities of Enovis’s remaining business with Enovis. Transition Services Agreement The transition services agreement sets forth the terms and conditions pursuant to which the Company and its subsidiaries and Enovis and its subsidiaries will provide to each other various services. The services to be provided include human resources, payroll, certain information technology services, treasury services and financial reporting services. The charges for the transition services generally are expected to allow the providing company to fully recover all internal and external costs and expenses it actually incurs in connection with providing the service (including a reasonable allocation of overhead) provided in the manner and at a level substantially consistent with that provided by the respective providing company immediately preceding the Distribution Date. As of the year ended December 31, 2023, the majority of the related obligations have been closed out. Tax Matters Agreement The tax matters agreement governs the Company’s and Enovis’s respective rights, responsibilities and obligations after the Separation with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and certain other matters regarding taxes. Employee Matters Agreement The employee matters agreement sets forth, among other things, the allocation of assets, liabilities and responsibilities relating to employee compensation and benefit plans and programs and other related matters in connection with the Separation, including the treatment of outstanding equity and other incentive awards and certain retirement and welfare benefit obligations. Stockholders and Registration Rights Agreement The stockholders and registration rights agreement sets forth the rights of the stockholders when requiring the Company to facilitate the resale of shares. Intellectual Property Matters Agreement The intellectual property matters agreement sets forth the terms and conditions pursuant to which Enovis and the Company have mutually granted certain personal, generally irrevocable, non-exclusive, worldwide and royalty-free rights to use certain intellectual property. The Company and Enovis are able to sublicense their rights in connection with activities relating to their businesses, but not for independent use by third parties. EBX License Agreement The EBX license agreement sets forth the terms and conditions pursuant to which Enovis has granted a royalty-free, non-exclusive, worldwide and nontransferable license to the Company to use EBX, solely in support of its businesses. The Company will be able to sublicense such license solely to direct and indirect wholly-owned subsidiaries. In addition, under the EBX license agreement, Enovis and the Company each license to each other improvements made by such party to EBX during the first two years of the term of the EBX license agreement. Allocated Expenses Prior to the Separation, the Company operated as part of the Former Parent and not as a stand-alone company. Accordingly, the Former Parent allocated certain shared costs to the Company that are reflected as expenses in these financial statements. These amounts included, but were not limited to, items such as general management and executive oversight, compliance, human resources, procurement and legal functions and financial management, including public company reporting, consolidated tax filings and tax planning. Management considered the allocation methodologies used by the Former Parent to be reasonable and to appropriately reflect the related expenses attributable to the Company for purposes of the three months ended April 1, 2022 and the year ended December 31, 2021 combined financial statements; however, the expenses reflected in these financial statements may not be indicative of the actual expenses that would have been incurred during the periods presented if the Company had operated as a separate stand-alone entity. In addition, the expenses reflected in the financial statements are not indicative of expenses the Company will incur in the future. Allocation methodologies utilized include the Company’s relative share of total Former Parent revenues and headcount. The Company had no stock-based compensation plans prior to the Separation; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans, which provided for the grants of stock options and RSUs among other types of awards. The expense associated with the Company's employees who participated in the plans of the Former Parent was allocated to the Company in the accompanying Consolidated and Combined Statements of Operations through the date of Separation. The Company’s allocated expenses from the Former Parent were $6.0 million for the three months ended April 1, 2022, and $29.5 million for the year ended December 31, 2021 and are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. Following the Separation, the Company independently incurs expenses as a stand-alone company. Refer to Note 14, “Benefit Plans,” for allocations of net periodic benefit associated with a Former Parent sponsored benefit plan.

Subsequent Events

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The dividend of $3.6 million included in Accrued liabilities in the Consolidated Balance Sheet at December 31, 2023 was paid on January 12, 2024, to stockholders of record as of December 29, 2023. In addition, on February 22, 2024, the Board of Directors declared a quarterly cash dividend of $0.06 per share of ESAB’s common stock payable on April 12, 2024, to stockholders of record as of March 29, 2024.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
Schedule II - Valuation and Qualifying Accounts	Dec. 31, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts	Balance at Charged to Cost and (1) Write-Offs Write-Downs Deductions and Other (2) Foreign Balance at (Dollars in thousands) Year Ended December 31, 2023: Allowance for credit losses $ 23,471 $ 3,902 $ (2,289) $ 393 $ 25,477 Valuation allowance for deferred tax assets 88,202 (12,283) — 3,436 79,355 Year Ended December 31, 2022: Allowance for credit losses $ 23,912 $ 4,526 $ (4,978) $ 11 $ 23,471 Valuation allowance for deferred tax assets (2) 15,465 4,503 68,876 (642) 88,202 Year Ended December 31, 2021: Allowance for credit losses $ 32,311 $ (494) $ (6,931) $ (974) $ 23,912 Valuation allowance for deferred tax assets 12,647 3,738 — (920) 15,465 (1) Amounts charged to expense are net of recoveries for the respective period. (2) As of December 31, 2022, valuation allowance for deferred tax assets “Other” of $68.9 million is primarily due to valuation allowance transferred from Former Parent.

Pay vs Performance Disclosure

Pay vs Performance Disclosure $ in Thousands	12 Months Ended
Pay vs Performance Disclosure $ in Thousands	Dec. 31, 2023 USD ($)
Pay vs Performance Disclosure
Net Income (Loss)	$ 205,285

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
Insider Trading Arrangements	Dec. 31, 2023 shares	Dec. 31, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Mr. Christopher M. Hix [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On November 15, 2023, Mr. Christopher M. Hix, a member of the Company’s Board of Directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 7,465 shares of Company common stock on March 1, 2024, subject to certain conditions, in order to satisfy certain tax obligations associated with the vesting of restricted stock units awarded to Mr. Hix in connection with his service as Chief Financial Officer of Enovis Corporation.
Name	Mr. Christopher M. Hix
Title	Board of Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 15, 2023
Aggregate Available	7,465	7,465
Ms. Michelle Campion [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On December 7, 2023, Ms. Michelle Campion, the Company’s Chief Human Resources Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 3,660 shares of Company common stock beginning on May 15, 2024, subject to certain conditions. On December 15, 2023, Ms. Campion terminated the trading plan.
Name	Ms. Michelle Campion
Title	Chief Human Resources Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 7, 2023
Rule 10b5-1 Arrangement Terminated	true
Termination Date	December 15, 2023
Aggregate Available	3,660	3,660

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2023
Accounting Policies [Abstract]
Fiscal Period	The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter.
Separation from Enovis and Principles of Consolidation	Separation from Enovis On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax,” “Enovis” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the spin-off and related distribution, collectively, the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. Upon completion of the Distribution, Colfax changed its name to Enovis Corporation and continued to hold 10% of the outstanding common stock of ESAB. In November 2022, Enovis sold a total of 6.0 million shares of the Company’s common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of the Company’s outstanding common stock. In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Separation Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement and license agreement for the EBX. Principles of Consolidation The Company’s Consolidated and Combined Financial Statements are prepared in accordance with GAAP and include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed in order to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest. All significant intercompany accounts and transactions have been eliminated.
Basis of Presentation	Basis of Presentation The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The combined financial statements for periods prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Re lated party a llocations prior to the Separation, including the method for such allocation, are discussed further in Note 21, “Related Party Transactions.” Following the Separation, the consolidated financial statements include ESAB and its wholly-owned subsidiaries and no longer include any allocations of expenses from Enovis. Accordingly: • The Consolidated Balance Sheets as of December 31, 2023 and December 31, 2022 con sist of the consolidated balances of ESAB. • The Consolidated Statement of Operations, Statement of Comprehensive Income (Loss), Statement of Changes in Equity and Statement of Cash Flows for the year ended December 31, 2023 consist of the consolidated results of ESAB. • The Consolidated and Combined Statement of Operations, Statement of Comprehensive Income (Loss), Statement of Changes in Equity and Statement of Cash Flows for the year ended December 31, 2022 consist of the activities of ESAB for the nine months ended December 31, 2022 and the combined activity of the former Fabrication Technology business of Enovis for the three months ended April 1, 2022. • The Consolidated and Combined Statement of Operations, Statement of Comprehensive Income (Loss), Statement of Changes in Equity and Statement of Cash Flows for the year ended December 31, 2021 consist of the combined activity of the former Fabrication Technology business of Enovis. Our Consolidated and Combined Financial Statements may not be indicative of the Company's results had it been a separate stand-alone entity throughout the periods pre-separation presented, nor are the results stated herein indicative of what the Company's financial position, results of operations and cash flows may be in the future. Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements under Enovis’s centralized approach to cash management and financing of its operations. With the exception of cash, cash equivalents and borrowings clearly associated with ESAB and related to the Separation, financing transactions relating to the Company during the period prior to the Separation were accounted for through the Former Parent’s investment account of the Company. Accordingly, none of Enovis’s cash, cash equivalents or debt at the corporate level has been assigned to the Company in these financial statements. Former Parent’s Investment, which included retained earnings, represented Enovis’s interest in the recorded net assets of the Company. All significant transactions between the Company and the Former Parent prior to the Separation have been included in the accompanying Financial Statements. Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Transfers to Former Parent, net” for the year ended December 31, 2021, and “ Net Transfers from Former Parent, including Separation Adjustments” for the year ended December 31, 2022. The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.
Use of Estimates	The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates. Use of Estimates The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.
Equity Method Investments	Equity Method Investments
Revenue Recognition	Revenue Recognition The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services. The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers , to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time. As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 6, “Revenue” and Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances and related information. The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred. Taxes Collected from Customers and Remitted to Governmental Authorities The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated Balance Sheets until remitted to the respective taxing authority.
Research and Development Expense	Research and Development Expense Research and development costs of $38.8 million
Cash and Cash Equivalents	Cash and Cash Equivalents
Trade Receivables	Trade Receivables
Inventories	Inventories Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost for a substantial portion of United States inventories is determined using the last-in, first-out (“LIFO”) method. The value of inventory stated on a LIFO basis as of December 31, 2023 and 2022 was $107.8 million and $131.1 million, respecti vely. The valuation of LIFO inventories is made at the end of each year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out basis. Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $47.6 million and $40.1 million as of December 31, 2023 and 2022, respectively.
Property, Plant and Equipment	Property, Plant and Equipment
Impairment of Goodwill and Indefinite-Lived Intangible Assets	Impairment of Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company. The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”). In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value. When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business. For the year ended December 31, 2023 and 2022, a qualitative Goodwill impairment assessment was performed for the three reporting units. For the year ended December 31, 2021, a quantitative annual impairment test of Goodwill was performed for the GCE reporting unit while qualitative assessments were performed for the remaining two reporting units. All of the above tests indicated no impairment existed. Therefore, no impairment charges were recorded for the three years ended December 31, 2023. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2023 annual impairment test. In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2023, 2022 and 2021, all of which indicated no impairment existed.
Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets	Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from ten The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. The Company determined that no significant impairment indicators were evident during the years ended December 31, 2023, 2022 and 2021.
Derivatives	Derivatives The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes. All derivatives are recognized at fair value on the Company’s Consolidated Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued. The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty. Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive income ("AOCI") with offsetting amounts recorded in the Company’s Consolidated Balance Sheet depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. Certain cross-currency swap agreements are designated and qualify as a net investment hedge, the changes in the fair value of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. Offsetting amounts are recorded in the Company’s Consolidated Balance Sheet depending on the position and the duration of the contract. The Company has certain foreign currency contracts which are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense (income) and other, net, in the Company’s Consolidated and Combined Statement of Operations.
Warranty Costs	Warranty Costs Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency and average costs of warranty claims.
Income Taxes	Income Taxes Prior to the Separation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. Prior to the Separation, all or a portion of the Company’s income tax payable or receivable computed under the separate return method was adjusted to equity as it did not represent a liability or asset with the relevant taxing authorities during this period, except for certain unrecognized tax benefits for which ESAB could have reasonably been considered to be the primary obligor. The amounts were deemed settled with Enovis when they were due and therefore were included in Parent’s equity. The Company accounts for income taxes under ASC 740 , Income Taxes (“ASC 740”) which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income is accounted for as a current tax expense in the year the tax is incurred. Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets. The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations.
Interest expense (income) and Other, Net	Interest expense (income) and Other, Net Interest expense (income) and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest income or expense of derivatives designated in hedging relationships. In addition, it is comprised of: • other non-operating expense (income) items, including certain pension-related activities, • foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships, and • Argentina highly inflationary accounting transaction foreign exchange loss on cash and cash equivalent remeasured into the Argentinian entity’s Brazilian real direct parent’s currency. For the years ended December 31, 2023 and 2022, Argentina had a transaction exchange loss on cash and cash equivalent of $26.2 million , and $2.4 million, partially offset by interest income of $8.7 million and $0.7 million, respectively. For the year ended December 31, 2021 , the impact was not material. See “Foreign Currency Exchange Gains and Losses” and “Argentina Highly Inflationary Accounting” policies below for additional information.
Foreign Currency Exchange Gains and Losses	Foreign Currency Exchange Gains and Losses The Company’s financial statements are presented in U.S. dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation are net of income taxes to the extent the unrealized foreign exchange is taxed currently or the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year. Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated Balance Sheets are recognized in Selling, general and administrative expense or Interest expense (income) and other, net in the Consolidated and Combined Statements of Operations for that period.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements The Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined financial statements as well as material updates to previous assessments. There were no new material accounting standards adopted in the year ended December 31, 2023 that impacted the Company. New Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires the disclosure of incremental information about significant segment expenses. The guidance also requires disclosure of the Chief Operating Decision Maker’s (the “CODM”) position for each segment and detail of how the CODM uses financial reporting to assess their segment’s performance. The new guidance is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024. The Company is currently evaluating the effect the adoption of the ASU may have on its disclosures. In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures , which expands disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. The ASU is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect the adoption of the ASU may have on its disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
Summary of Significant Accounting Policies (Tables)	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location	The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following: Year Ended December 31, Derivative type Gain recognized in the Consolidated and Combined Statements of Operations: 2023 2022 Cross currency swap agreements Interest expense (income) and other, net $ (4,779) $ (2,181)
Schedule of Net Foreign Transaction Gains and Losses	The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations: Year Ended December 31, 2023 2022 2021 (In thousands) (1) Selling, general and administrative expense $ 11,389 $ 2,597 $ 2,195 Interest expense and other, net 1,719 109 191 Foreign currency transaction loss, net (2) $ 13,108 $ 2,706 $ 2,386 (1) This table excludes the foreign exchange impacts of applying highly inflationary accounting for the Company’s Argentina operations for the years ended December 31, 2023 and 2022, as described in the “Argentina Highly Inflationary Accounting” paragraph below. (2) During 2023, the weakening of the Ruble and certain other South American currencies drove the increase in the loss on transactions denominated in foreign currencies.

Revenue (Tables)

Revenue (Tables)	12 Months Ended
Revenue (Tables)	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The Company disaggregates its revenue into the following product groups: Year Ended December 31, 2023 2022 2021 (In thousands) Equipment $ 854,949 $ 740,824 $ 758,267 Consumables 1,919,817 1,852,656 1,669,848 Total $ 2,774,766 $ 2,593,480 $ 2,428,115
Schedule of Accounts Receivable, Allowance for Credit Loss	A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated Balance Sheets is as follows: Year Ended December 31, 2023 Balance at Charged to Expense, net Write-Offs and Deductions Foreign Balance at (In thousands) Allowance for credit losses $ 23,471 $ 3,902 $ (2,289) $ 393 $ 25,477

Earnings per Share from Conti_2

Earnings per Share from Continuing Operations (Tables)	12 Months Ended
Earnings per Share from Continuing Operations (Tables)	Dec. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share from Continuing Operations	The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows: Year Ended December 31, 2023 2022 2021 (In thousands, except share and per share data) Computation of earnings per share from continuing operations - basic: Income from continuing operations attributable to ESAB Corporation (1) $ 217,626 $ 226,815 $ 235,110 Less: distributed and undistributed earnings allocated to nonvested shares (1,555) (1,600) — Income from continuing operations attributable to common stockholders $ 216,071 $ 225,215 $ 235,110 Weighted-average shares of Common stock outstanding – basic (2) 60,233,623 60,054,930 60,034,311 Income per share from continuing operations – basic $ 3.59 $ 3.75 $ 3.92 Computation of earnings (loss) per share from continuing operations - diluted: Income from continuing operations attributable to common stockholders $ 216,071 $ 225,215 $ 235,110 Weighted-average shares of Common stock outstanding – basic (2) 60,233,623 60,054,930 60,034,311 Net effect of potentially dilutive securities (3) 422,123 98,129 — Weighted-average shares of Common stock outstanding – dilution 60,655,746 60,153,059 60,034,311 Net income per share from continuing operations – diluted $ 3.56 $ 3.74 $ 3.92 (1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, o f $5.7 million, $4.3 million and $3.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. (2) The total number of shares outstanding on April 4, 2022 was 60,034,311, which is utilized for the calculation of both basic and diluted earnings per share for the year ended December 31, 2021 as no ESAB common stock equivalents were outstanding prior to the Separation. (3) Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	Income from continuing operations before income taxes and Income tax expense consisted of the following: Year Ended December 31, 2023 2022 2021 (In thousands) Income from continuing operations before income taxes: Domestic operations $ 37,364 $ (19,234) $ 10,140 Foreign operations 281,728 319,485 308,948 $ 319,092 $ 300,251 $ 319,088 Income tax expense: Current: Federal $ 18,034 $ 8,928 $ 18,477 State 3,760 2,451 1,797 Foreign 99,036 77,728 68,779 120,830 89,107 89,053 Deferred: Federal (11,897) (7,501) (12,700) State (1,341) 358 161 Foreign (11,865) (12,794) 3,895 (25,103) (19,937) (8,644) $ 95,727 $ 69,170 $ 80,409
Schedule of Components of Income Tax Expense (Benefit)	Income from continuing operations before income taxes and Income tax expense consisted of the following: Year Ended December 31, 2023 2022 2021 (In thousands) Income from continuing operations before income taxes: Domestic operations $ 37,364 $ (19,234) $ 10,140 Foreign operations 281,728 319,485 308,948 $ 319,092 $ 300,251 $ 319,088 Income tax expense: Current: Federal $ 18,034 $ 8,928 $ 18,477 State 3,760 2,451 1,797 Foreign 99,036 77,728 68,779 120,830 89,107 89,053 Deferred: Federal (11,897) (7,501) (12,700) State (1,341) 358 161 Foreign (11,865) (12,794) 3,895 (25,103) (19,937) (8,644) $ 95,727 $ 69,170 $ 80,409
Schedule of Effective Income Tax Rate Reconciliation	The Company’s Income tax expense differs from the amount that would be computed by applying the United States federal statutory rate as follows: Year Ended December 31, 2023 2022 2021 (In thousands) Taxes calculated at the United States federal statutory rate $ 67,010 $ 63,053 $ 67,008 State taxes 1,630 2,809 1,933 Effect of tax rates on international operations 1,548 (9,010) (8,879) Changes in tax reserves 10,753 (350) 2,734 Non-taxable dividends — — (46) Research and development tax credits (714) (542) (587) Effect of United States taxation on international operations 1,527 310 (313) Permanent differences, net 10,077 7,209 483 Provision to return 703 (7,055) (7,415) Withholding taxes 11,172 12,133 9,567 Capital gain — (3,655) 12,371 Valuation Allowance (12,308) 4,503 3,737 Other 4,329 (235) (184) Income tax expense $ 95,727 $ 69,170 $ 80,409
Schedule of Deferred Tax Assets and Liabilities	The temporary differences that gave rise to the significant components of deferred tax assets and liabilities are presented below: December 31, 2023 2022 (In thousands) Deferred tax assets: Post-retirement benefit obligation $ 1,350 $ 5,761 Expenses currently not deductible 52,526 36,320 Net operating loss carryforward 107,395 111,497 Tax credit carryforward 4,581 10,320 Depreciation and amortization 7,404 9,124 Inventory 12,238 5,685 Capitalized R&D Costs 18,178 14,160 Leases 23,987 22,713 Other 2,866 — Valuation allowance (79,354) (88,202) Deferred tax assets, net $ 151,171 $ 127,378 Deferred tax liabilities: Depreciation and amortization $ (120,055) $ (121,858) Leases (23,987) (22,713) Outside basis differences and other (79,985) (79,623) Total deferred tax liabilities $ (224,027) $ (224,194) Total deferred tax liabilities, net $ (72,856) $ (96,816) Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets on a net jurisdictional basis as follows: December 31, 2023 2022 (In thousands) Other assets $ 46,602 $ 42,860 Other liabilities (119,458) (139,676) Deferred tax liability, net $ (72,856) $ (96,816)
Schedule of Income Tax Contingencies	A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (inclusive of associated interest and penalties): (In thousands) Balance, January 1, 2021 $ 35,201 Addition for tax positions taken in prior periods 738 Addition for tax positions taken in the current period 2,987 Reductions related to settlements with taxing authorities (425) Reductions resulting from a lapse of applicable statute of limitations (565) Other, including the impact of foreign currency translation and United States tax rate changes (255) Balance, December 31, 2021 37,681 Addition for tax positions taken in prior periods 1,971 Addition for tax positions taken in the current period 1,171 Reductions related to settlements with taxing authorities (922) Transfer from Former Parent, impact of foreign currency translation and other (2,801) Other, including the impact of foreign currency translation and United States tax rate changes (16,897) Balance, December 31, 2022 20,203 Addition for tax positions taken in prior periods 13,514 Addition for tax positions taken in the current period — Reductions related to settlements with taxing authorities (4,160) Reductions resulting from a lapse of applicable statute of limitations (473) Other, including the impact of foreign currency translation 1,787 Balance, December 31, 2023 $ 30,871

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
Goodwill and Intangible Assets (Tables)	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes Goodwill activity by segment for the years ended December 31, 2023 and 2022: Americas EMEA & APAC Total (In thousands) Balance, January 1, 2022 $ 519,154 $ 1,013,839 $ 1,532,993 Goodwill attributable to acquisition 63,183 13,047 76,230 Impact of foreign currency translation 3,508 (82,964) (79,456) Balance, December 31, 2022 585,845 943,922 1,529,767 Goodwill attributable to acquisitions 1,664 13,912 15,576 Impact of foreign currency translation 2,366 40,622 42,988 Balance, December 31, 2023 $ 589,875 $ 998,456 $ 1,588,331
Schedule of Indefinite-Lived Intangible Assets	The following table summarizes the Company’s Intangible assets, excluding Goodwill: December 31, 2023 2022 Gross Accumulated Gross Accumulated (In thousands) Indefinite-Lived Intangible Assets Trade names $ 185,301 $ — $ 180,691 $ — Definite-Lived Intangible Assets Customer relationships 496,483 (231,848) 482,499 (203,041) Technology 73,288 (55,288) 71,192 (50,005) Trade names 23,966 (10,983) 22,464 (9,412) Software 80,203 (61,920) 94,904 (74,799) Other intangible assets 22,878 (22,545) 22,800 (20,126) $ 882,119 $ (382,584) $ 874,550 $ (357,383)
Schedule of Finite-Lived Intangible Assets	The following table summarizes the Company’s Intangible assets, excluding Goodwill: December 31, 2023 2022 Gross Accumulated Gross Accumulated (In thousands) Indefinite-Lived Intangible Assets Trade names $ 185,301 $ — $ 180,691 $ — Definite-Lived Intangible Assets Customer relationships 496,483 (231,848) 482,499 (203,041) Technology 73,288 (55,288) 71,192 (50,005) Trade names 23,966 (10,983) 22,464 (9,412) Software 80,203 (61,920) 94,904 (74,799) Other intangible assets 22,878 (22,545) 22,800 (20,126) $ 882,119 $ (382,584) $ 874,550 $ (357,383)
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The Company’s expected annual amortization expense for acquired intangible assets for the next five years is as follows: December 31, 2023 (In thousands) 2024 $ 29,160 2025 28,115 2026 27,027 2027 22,562 2028 20,782

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	12 Months Ended
Property, Plant and Equipment, Net (Tables)	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	December 31, Depreciable Life 2023 2022 (In years) (In thousands) Land n/a $ 15,095 $ 15,839 Buildings and improvements 5-40 178,682 164,472 Machinery and equipment 3-15 394,318 382,830 588,095 563,141 Accumulated depreciation (293,790) (278,915) $ 294,305 $ 284,226

Inventories, Net (Tables)

Inventories, Net (Tables)	12 Months Ended
Inventories, Net (Tables)	Dec. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventories, net consisted of the following: December 31, 2023 2022 (In thousands) Raw materials $ 156,583 $ 153,099 Work in process 43,561 44,086 Finished goods 244,580 261,902 444,724 459,087 LIFO reserve (4,279) (2,168) Less: allowance for excess, slow-moving and obsolete inventory (47,587) (40,090) $ 392,858 $ 416,829

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Dec. 31, 2023
Leases [Abstract]
Schedule of Future Minimum Lease Payments	December 31, 2023 (In thousands) Future lease payments by year: 2024 $ 25,769 2025 20,540 2026 14,366 2027 9,938 2028 8,645 Thereafter 32,190 Total 111,448 Less: present value discount (12,045) Present value of lease liabilities $ 99,403 Weighted-average remaining lease term (in years): Operating leases 6.62 Weighted-average discount rate: Operating leases 3.5 %

Accrued and Other Liabilities (

Accrued and Other Liabilities (Tables)	12 Months Ended
Accrued and Other Liabilities (Tables)	Dec. 31, 2023
Accrued Liabilities [Abstract]
Schedule of Accrued and Other Liabilities	Accrued and Other liabilities in the Consolidated Balance Sheets consisted of the following: December 31, 2023 December 31, 2022 Current Noncurrent Current Noncurrent (In thousands) Accrued taxes and deferred tax liabilities $ 45,681 $ 144,662 $ 49,615 $ 161,500 Compensation and related benefits 97,052 52,589 74,794 57,438 Asbestos liability 32,908 234,796 30,108 230,581 Contract liability 31,248 — 25,899 — Lease liability 22,794 76,609 18,664 76,163 Warranty liability 12,606 — 12,946 — Third-party commissions 18,711 — 18,315 — Restructuring liability 5,345 354 7,533 285 Other 47,144 33,823 47,436 19,372 $ 313,489 $ 542,833 $ 285,310 $ 545,339
Schedule of Product Warranty Liability	A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated Balance Sheets is as follows: Year Ended December 31, 2023 2022 (In thousands) Warranty liability, beginning of period $ 12,946 $ 14,954 Accrued warranty expense 5,794 5,322 Changes in estimates related to pre-existing warranties 3,097 2,821 Cost of warranty service work performed (10,710) (9,680) Acquisition-related liability 1,278 — Foreign exchange translation effect 201 (471) Warranty liability, end of period $ 12,606 $ 12,946
Schedule of Restructuring Reserve by Type of Cost	A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated Balance Sheets is as follows: Year Ended December 31, 2023 Balance at Beginning of Period Charges Payments Foreign Currency Translation Balance at End of Period (In thousands) Restructuring and other related charges: Termination benefits (1) $ 4,910 $ 10,017 $ (10,223) $ (109) $ 4,595 Facility closure costs and other (2) 2,908 8,637 (10,483) 42 1,104 Subtotal $ 7,818 18,654 $ (20,706) $ (67) $ 5,699 Non-cash charges (3) 5,456 Total $ 24,110 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines. (3) Includes impairment of long-lived assets in connection with the closure and optimization of facilities and product lines. Year Ended December 31, 2022 Balance at Beginning of Period Charges Payments Foreign Currency Translation Balance at End of Period (In thousands) Restructuring and other related charges: Termination benefits (1) $ 7,818 $ 4,642 $ (7,626) $ 76 $ 4,910 Facility closure costs (2) 291 17,656 (15,068) 29 2,908 Subtotal $ 8,109 22,298 $ (22,694) $ 105 $ 7,818 Non-cash charges (3) 798 Total $ 23,096 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines. (3) Includes impairment of long-lived assets in connection with the closure and optimization of facilities and product lines.

Benefit Plans (Tables)

Benefit Plans (Tables)	12 Months Ended
Benefit Plans (Tables)	Dec. 31, 2023
Retirement Benefits [Abstract]
Schedule of Changes in Projected Benefit Obligations	The following table summarizes the total changes in the Company’s pension and accrued post-retirement benefits and plan assets and includes a statement of the plans’ funded status: Pension Benefits Other Post-Retirement Benefits Year Ended December 31, Year Ended December 31, 2023 2022 2023 2022 (In thousands) Change in benefit obligation: Projected benefit obligation, beginning of year $ 256,022 $ 142,914 $ 8,850 $ 382 Transfer from Former Parent — 200,690 — 11,697 Service cost 1,439 1,684 11 15 Interest cost 11,170 5,874 393 234 Plan amendments 175 862 — — Actuarial loss (gain) 802 (60,148) (514) (2,807) Foreign exchange effect 4,079 (12,452) (1) (35) Benefits paid (27,720) (23,385) (549) (636) Settlements (3,584) (283) — — Other 360 266 — — Projected benefit obligation, end of year $ 242,743 $ 256,022 $ 8,190 $ 8,850 Accumulated benefit obligation, end of year $ 239,578 $ 253,123 $ 8,190 $ 8,850 Change in plan assets: Fair value of plan assets, beginning of year $ 219,050 $ 84,503 $ — $ — Transfer from Former Parent — 201,259 — — Actual return on plan assets 19,651 (51,266) — — Employer contributions (1) (857) 5,315 549 636 Foreign exchange effect 3,162 (7,583) — — Benefits paid (27,720) (23,385) (549) (636) Settlements (2,505) 9,947 — — Other 691 260 — — Fair value of plan assets, end of year $ 211,472 $ 219,050 $ — $ — Funded status, end of year $ (31,271) $ (36,972) $ (8,190) $ (8,850) Amounts recognized on the Consolidated Balance Sheets as of December 31: Non-current assets $ 17,300 $ 15,701 $ — $ — Current liabilities (3,186) (3,025) (764) (824) Non-current liabilities (45,385) (49,648) (7,426) (8,026) Total $ (31,271) $ (36,972) $ (8,190) $ (8,850) (1) The employer contribution amount for the year ended December 31, 2023 includes a refund of assets totaling $5.1 million to the Company arising from a completed wind up of a foreign defined benefit plan. The following table summarizes the changes in the Company’s foreign pension benefit obligations and plan assets, included in the table above, and includes a statement of the plans’ funded status: Foreign Pension Benefits Year Ended December 31, 2023 2022 (In thousands) Change in benefit obligation: Projected benefit obligation, beginning of year $ 99,401 $ 141,278 Service cost 1,439 1,684 Interest cost 4,148 2,161 Plan amendments 175 862 Actuarial loss (gain) 335 (25,131) Foreign exchange effect 4,079 (12,452) Benefits paid (7,138) (8,984) Settlements (3,584) (283) Other 360 266 Projected benefit obligation, end of year $ 99,215 $ 99,401 Accumulated benefit obligation, end of year $ 96,049 $ 96,500 Change in plan assets: Fair value of plan assets, beginning of year $ 70,821 $ 84,503 Actual return on plan assets 1,262 (12,494) Employer contributions (1,015) 5,170 Foreign exchange effect 3,162 (7,581) Benefits paid (7,138) (8,984) Settlements (2,505) 9,947 Other 691 260 Fair value of plan assets, end of year $ 65,278 $ 70,821 Funded status, end of year $ (33,937) $ (28,580)
Schedule of Expected Benefit Payments	The following benefit payments are expected to be paid during each respective fiscal year: Pension Benefits Other Post-Retirement Benefits All Plans Foreign Plans (In thousands) 2024 $ 21,183 $ 7,256 $ 764 2025 20,635 7,074 745 2026 20,300 7,138 744 2027 19,912 7,175 740 2028 19,134 6,802 688 2029 - 2033 89,736 35,683 3,055
Schedule of Allocation of Plan Assets	The following are the actual allocation percentages for the Company’s pension plan assets: Actual Asset Allocation December 31, 2023 2022 United States Plans: Equity securities: United States 38 % 36 % International 12 % 13 % Fixed income 49 % 50 % Cash and cash equivalents 1 % 1 % Foreign Plans: Equity securities 1 % 4 % Fixed income securities 48 % 34 % Cash and cash equivalents 1 % 16 % Insurance contracts 38 % 34 % Investment funds (1) 12 % 12 % (1) Represents various fixed income and equity securities. A summary of the Company’s pension plan assets for each fair value hierarchy level for the periods presented follows (see Note 17, “Fai r Value Measurements” for further description of the levels within the fair value hierarchy): December 31, 2023 Measured at Net Asset Value (1) Level Level Level (In thousands) United States Plans: Cash and cash equivalents $ — $ 1,237 $ — $ — $ 1,237 Equity securities: United States large cap 29,289 — — — 29,289 United States small/mid cap 10,130 16,033 — — 26,163 International 18,078 — — — 18,078 Fixed income mutual funds: United States government and corporate 70,283 — — — 70,283 Other — 1,145 — — 1,145 Foreign Plans: Cash and cash equivalents (2) — 547 — — 547 Equity securities — 921 — — 921 Non-United States government and corporate bonds — 31,147 — — 31,147 Insurance contracts — — 24,592 — 24,592 Investment funds — — 8,050 — 8,050 Other — — 20 — 20 $ 127,780 $ 51,030 $ 32,662 $ — $ 211,472 (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, which are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term. (2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets. December 31, 2022 Measured at Net Asset Value (1) Level Level Level (In thousands) United States Plans: Cash and cash equivalents $ — $ 1,591 $ — $ — $ 1,591 Equity securities: United States large cap 31,018 — — — 31,018 United States small/mid cap 10,789 11,289 — — 22,078 International 18,928 — — — 18,928 Fixed income mutual funds: United States government and corporate 73,497 — — — 73,497 Other — 1,118 — — 1,118 Foreign Plans: Cash and cash equivalents (2) — 11,348 — — 11,348 Equity securities — 2,475 — — 2,475 Non-United States government and corporate bonds — 24,289 — — 24,289 Insurance contracts — — 24,236 — 24,236 Investment funds — — 8,400 — 8,400 Other — 33 39 — 72 $ 134,232 $ 52,143 $ 32,675 $ — $ 219,050 (1) Certain investments that are measured at fair value using the NAV have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, which are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term. (2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
Schedule of Net Benefit Costs	The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans: Pension Benefits Other Post-Retirement Benefits Year Ended December 31, Year Ended December 31, 2023 2022 2021 2023 2022 2021 (In thousands) Components of Net Periodic Benefit (Income) Cost: Service cost $ 1,439 $ 1,684 $ 1,785 $ 11 $ 15 $ 14 Interest cost 11,170 5,874 1,668 393 234 22 Amortization 1,206 4,313 1,220 — (181) — Settlement (gain) loss — (9,114) (11,195) — — 8 Other — 92 2 — — — Expected return on plan assets (11,391) (11,519) (2,258) — — — Net periodic benefit cost (income) $ 2,424 $ (8,670) $ (8,778) $ 404 $ 68 $ 44 Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Transfer from Former Parent $ — $ 53,134 $ — $ — $ (2,629) $ — Current year net actuarial (gain) loss (7,021) 949 (5,788) (514) (2,807) (27) Current year prior service cost 175 862 — — — — Less amounts included in net periodic benefit cost: Amortization of net (loss) gain (1,575) (4,340) (1,228) 479 181 (8) Settlement/divestiture/other loss (1,079) (67) — — — — Amortization of prior service cost 38 (1,067) (5) — — — Total recognized in Other comprehensive (gain) loss $ (9,462) $ 49,471 $ (7,021) $ (35) $ (5,255) $ (35) The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above: Foreign Pension Benefits Year Ended December 31, 2023 2022 2021 (In thousands) Components of Net Periodic Benefit (Income) Cost: Service cost $ 1,439 $ 1,684 $ 1,785 Interest cost 4,148 2,161 1,646 Amortization 40 687 1,118 Settlement gain — (9,114) (11,195) Other (331) 92 2 Expected return on plan assets (2,475) (2,063) (2,258) Net periodic benefit cost (income) $ 2,821 $ (6,553) $ (8,902) Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Current year net actuarial loss (gain) $ 1,984 $ (12,262) $ (5,710) Current year prior service cost 175 862 — Less amounts included in net periodic benefit (income) cost: Amortization of net loss (78) (714) (1,126) Settlement/divestiture/other loss (1,079) (67) — Amortization of prior service cost 38 (1,067) (5) Total recognized in Other comprehensive loss (gain) $ 1,040 $ (13,248) $ (6,841)
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)	The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans: Pension Benefits Other Post-Retirement Benefits Year Ended December 31, Year Ended December 31, 2023 2022 2021 2023 2022 2021 (In thousands) Components of Net Periodic Benefit (Income) Cost: Service cost $ 1,439 $ 1,684 $ 1,785 $ 11 $ 15 $ 14 Interest cost 11,170 5,874 1,668 393 234 22 Amortization 1,206 4,313 1,220 — (181) — Settlement (gain) loss — (9,114) (11,195) — — 8 Other — 92 2 — — — Expected return on plan assets (11,391) (11,519) (2,258) — — — Net periodic benefit cost (income) $ 2,424 $ (8,670) $ (8,778) $ 404 $ 68 $ 44 Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Transfer from Former Parent $ — $ 53,134 $ — $ — $ (2,629) $ — Current year net actuarial (gain) loss (7,021) 949 (5,788) (514) (2,807) (27) Current year prior service cost 175 862 — — — — Less amounts included in net periodic benefit cost: Amortization of net (loss) gain (1,575) (4,340) (1,228) 479 181 (8) Settlement/divestiture/other loss (1,079) (67) — — — — Amortization of prior service cost 38 (1,067) (5) — — — Total recognized in Other comprehensive (gain) loss $ (9,462) $ 49,471 $ (7,021) $ (35) $ (5,255) $ (35) The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above: Foreign Pension Benefits Year Ended December 31, 2023 2022 2021 (In thousands) Components of Net Periodic Benefit (Income) Cost: Service cost $ 1,439 $ 1,684 $ 1,785 Interest cost 4,148 2,161 1,646 Amortization 40 687 1,118 Settlement gain — (9,114) (11,195) Other (331) 92 2 Expected return on plan assets (2,475) (2,063) (2,258) Net periodic benefit cost (income) $ 2,821 $ (6,553) $ (8,902) Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Current year net actuarial loss (gain) $ 1,984 $ (12,262) $ (5,710) Current year prior service cost 175 862 — Less amounts included in net periodic benefit (income) cost: Amortization of net loss (78) (714) (1,126) Settlement/divestiture/other loss (1,079) (67) — Amortization of prior service cost 38 (1,067) (5) Total recognized in Other comprehensive loss (gain) $ 1,040 $ (13,248) $ (6,841)
Schedule of Net Periodic Benefit Cost Not yet Recognized	The components of net unrecognized pension and other post-retirement benefit cost included in Accumulated other comprehensive loss in the Consolidated Balance Sheets that have not been recognized as a component of net periodic benefit cost are as follows: Pension Benefits Other Post-Retirement December 31, December 31, 2023 2022 2023 2022 (In thousands) Net actuarial loss (gain) $ 61,573 $ 71,066 $ (5,234) $ (5,199) Prior service income (81) (112) — — Total $ 61,492 $ 70,954 $ (5,234) $ (5,199)
Schedule of Assumptions Used	The key economic assumptions used in the measurement of the Company’s pension and other post-retirement benefit obligations are as follows: Pension Benefits Other Post-Retirement December 31, December 31, 2023 2022 2023 2022 Weighted-average discount rate: All plans 4.4 % 4.6 % 4.8 % 5.0 % Foreign plans 3.9 % 4.3 % — % — % Weighted-average rate of increase in compensation levels for active foreign plans (1) 3.1 % 3.2 % — % — % (1) Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. The key economic assumptions used in the computation of net periodic benefit cost are as follows: Pension Benefits Other Post-Retirement Benefits Year Ended December 31, Year Ended December 31, 2023 2022 2021 2023 2022 2021 Weighted-average discount rate: All plans 4.6 % 2.2 % 1.3 % — % 2.6 % 6.0 % Foreign plans 4.3 % 1.9 % 1.3 % — % — % — % Weighted-average expected return on plan assets: All plans 5.0 % 4.8 % 3.6 % — % — % — % Foreign plans 4.1 % 3.2 % 3.6 % — % — % — % Weighted-average rate of increase in compensation levels for active foreign plans (1) 3.2 % 3.2 % 3.4 % — % — % — % (1)

Debt (Tables)

Debt (Tables)	12 Months Ended
Debt (Tables)	Dec. 31, 2023
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	Long-term debt consists of the following: December 31, 2023 2022 (In thousands) Term loans $ 987,500 $ 1,000,000 Revolving credit facilities 32,000 221,000 Total debt 1,019,500 1,221,000 Unamortized deferred financing fees (1,443) (2,357) Long-term debt $ 1,018,057 $ 1,218,643
Schedule of the Contractual Maturities of the Company's Debt	The Company’s minimum principal payments for the next five years are as follows: December 31, 2023 (in thousands) 2024 $ — 2025 592,500 2026 — 2027 427,000 2028 — Total debt (1) $ 1,019,500 (1) Total debt excludes $1.4 million of related unamortized deferred financing fees.

Derivatives (Tables)

Derivatives (Tables)	12 Months Ended
Derivatives (Tables)	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	The effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following: Year Ended December 31, Derivative type (Gain) loss recognized in the Consolidated and Combined Statements of Operations: 2023 2022 (In thousands) Interest rate swap agreements Interest expense (income) and other, net $ (11,053) $ 413
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The table below shows the fair value of the derivatives recognized in the Company’s Consolidated Balance Sheets: December 31, 2023 December 31, 2022 Designated as hedging instruments Other Liabilities Other Assets Other Liabilities Other Assets (In thousands) Cross currency swap agreements $ 22,232 $ — $ 10,769 $ — Interest rate swap agreements — 9,522 — 14,342 Total $ 22,232 $ 9,522 $ 10,769 $ 14,342
Derivatives Not Designated as Hedging Instruments	The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Company’s Consolidated Balance Sheets: December 31, 2023 December 31, 2022 Not designated as hedging instruments Accrued Liabilities Other Current Assets Accrued Liabilities Other Current Assets (In thousands) Foreign currency contracts $ 596 $ 1,088 $ 2,166 $ 3,682
Schedule of Derivative Instruments	The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship: Year Ended December 31, Foreign currency contracts 2023 2022 2021 (In thousands) Change in unrealized (loss) gain (1,023) 1,338 177 Realized loss (1) (2,928) (17,601) (5,631) (1)
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location	The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following: Year Ended December 31, Derivative type Gain recognized in the Consolidated and Combined Statements of Operations: 2023 2022 Cross currency swap agreements Interest expense (income) and other, net $ (4,779) $ (2,181)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value	A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows (see Note 14, “Benefit Plan s” for classification of the assets of the Company’s benefit plans within the fair value hierarchy): December 31, 2023 Level Level Level Total (In thousands) Assets: Cash equivalents $ 6,027 $ — $ — $ 6,027 Foreign currency contracts - not designated as hedges — 2,261 — 2,261 Interest rate swap agreements — 9,522 — 9,522 Deferred compensation plans — 3,488 — 3,488 $ 6,027 $ 15,271 $ — $ 21,298 Liabilities: Foreign currency contracts - not designated as hedges $ — $ 1,769 $ — $ 1,769 Cross currency swap agreements — 22,232 — 22,232 Deferred compensation plans — 3,488 — 3,488 $ — $ 27,489 $ — $ 27,489 December 31, 2022 Level Level Level Total (In thousands) Assets: Cash equivalents $ 8,195 $ — $ — $ 8,195 Foreign currency contracts - not designated as hedges — 3,682 — 3,682 Interest rate swap agreements — 14,342 — 14,342 Deferred compensation plans — 2,501 — 2,501 $ 8,195 $ 20,525 $ — $ 28,720 Liabilities: Foreign currency contracts - not designated as hedges $ — $ 2,166 $ — $ 2,166 Cross currency swap agreements — 10,769 — 10,769 Deferred compensation plans — 2,501 — 2,501 $ — $ 15,436 $ — $ 15,436

Equity (Tables)

Equity (Tables)	12 Months Ended
Equity (Tables)	Dec. 31, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The following table presents the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the years ended December 31, 2023, 2022 and 2021. All amounts are net of tax and noncontrolling interest, if any. Accumulated Other Comprehensive Loss Components Net Unrecognized Pension and Other Post-Retirement Benefit Cost Foreign Currency Translation Adjustment Net Investment Hedges Cash Flow Hedges Total (In thousands) Balance at January 1, 2021 $ (29,378) $ (366,825) $ — $ — $ (396,203) Other comprehensive income (loss) before reclassifications: $ — Net actuarial gain 7,479 — — — 7,479 Foreign currency translation adjustment 1,534 (72,867) — — (71,333) Other comprehensive (loss) income before reclassifications 9,013 (72,867) — — (63,854) Amounts reclassified from Accumulated other comprehensive loss (1) (831) — — — (831) Net current period Other comprehensive (loss) income 8,182 (72,867) — — (64,685) Balance at December 31, 2021 (21,196) (439,692) — — (460,888) Other comprehensive income (loss) before reclassifications: Amounts contributed by Former Parent (2) (50,504) (8,759) — — (59,263) Net actuarial gain 113 — — — 113 Foreign currency translation adjustment 1,712 (82,351) (8,336) — (88,975) Loss on long-term intra-entity foreign currency transactions — (83,105) — — (83,105) Unrealized gain on cash flow hedges — — — 10,782 10,782 Other comprehensive (loss) income before reclassifications (48,679) (174,215) (8,336) 10,782 (220,448) Amounts reclassified from Accumulated other comprehensive loss (1) 6,028 — — 320 6,348 Net current period Other comprehensive (loss) income (42,651) (174,215) (8,336) 11,102 (214,100) Balance at December 31, 2022 (63,847) (613,907) (8,336) 11,102 (674,988) Other comprehensive income (loss) before reclassifications: Net actuarial gain 8,969 — — — 8,969 Foreign currency translation adjustment (3,285) (11,143) (8,879) — (23,307) Gain on long-term intra-entity foreign currency transactions — 70,428 — — 70,428 Unrealized gain on cash flow hedges — — — 4,834 4,834 Other comprehensive (loss) income before reclassifications 5,684 59,285 (8,879) 4,834 60,924 Amounts reclassified from Accumulated other comprehensive loss (1)(3) (1,642) — — (8,566) (10,208) Net current period Other comprehensive (loss) income 4,042 59,285 (8,879) (3,732) 50,716 Balance at December 31, 2023 $ (59,805) $ (554,622) $ (17,215) $ 7,370 $ (624,272) (1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14, “Benefit Plans” for additional details. (2) Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities which were part of the Corporate segment of the Former Parent and were transferred to ESAB Corporation in anticipation of the Separation. (3) During the years ended December 31, 2023 and 2022, the amount on this line within the Cash Flow Hedges column is a component of Interest expense (income) and other, net. See Note 16, “Derivatives,” for additional details.
Schedule of Nonvested Share Activity	The activity of the Company’s PRSUs and RSUs is as follows: PRSUs RSUs Number Weighted- Number Weighted- Balance at December 31, 2022 110,288 $ 53.99 464,278 $ 50.80 Granted 83,873 61.32 183,605 61.46 Vested (19,062) 59.42 (152,907) 51.00 Forfeited and expired (6,124) 61.32 (55,346) 53.52 Balance at December 31, 2023 168,975 56.75 439,630 54.84

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
Commitments and Contingencies (Tables)	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule Of Loss Contingencies By Claims Quantities	Asbestos-related claims activity since December 31, 2022 and 2021, respectively, is as follows: Year Ended December 31, 2023 2022 (Number of claims) Claims unresolved, beginning of period 14,106 14,559 Claims filed (1) 4,627 4,338 Claims resolved (2) (5,085) (4,791) Claims unresolved, end of period 13,648 14,106 (In dollars) Average cost of resolved claims (3) $ 9,524 $ 10,017 (1) Claims filed include all asbestos claims for which notification has been received or a file has been opened. (2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants. (3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.
Schedule Of Asbestos Related Litigation	The Company’s Consolidated Balance Sheets include the following amounts related to asbestos-related litigation: December 31, 2023 2022 (In thousands) Long-term asbestos insurance asset (1) $ 221,489 $ 215,112 Long-term asbestos insurance receivable (1) 17,868 17,231 Accrued asbestos liability (2) 32,908 30,108 Long-term asbestos liability (3) 234,796 230,581 (1) Included in Other assets in the Consolidated Balance Sheets. (2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets. (3) Included in Other liabilities in the Consolidated Balance Sheets.

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
Segment Information (Tables)	Dec. 31, 2023
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	The Company’s segment results were as follows: Year Ended December 31, 2023 2022 2021 (In thousands) Net sales (1) : Americas $ 1,214,998 $ 1,128,306 $ 1,004,208 EMEA & APAC 1,559,768 1,465,174 1,423,907 $ 2,774,766 $ 2,593,480 $ 2,428,115 Adjusted EBITDA (2) : Americas $ 224,742 $ 188,577 $ 159,623 EMEA & APAC 276,360 248,177 244,458 $ 501,102 $ 436,754 $ 404,081 Depreciation, amortization and other impairment charges: Americas $ 34,589 $ 29,281 $ 33,890 EMEA & APAC 40,445 36,697 42,009 $ 75,034 $ 65,978 $ 75,899 Capital expenditures: Americas $ 21,576 $ 18,005 $ 14,095 EMEA & APAC 26,602 22,238 21,489 $ 48,178 $ 40,243 $ 35,584 (1) For the years ended December 31, 2023, 2022 and 2021, the total Net sales originating from the United States were $619.1 million, $583.0 million and $533.5 million, respectively. The remainder of the sales were derived from foreign countries. (2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA: Year Ended December 31, 2023 2022 2021 (In thousands) Net income from continuing operations $ 223,365 $ 231,081 $ 238,679 Income tax expense 95,727 69,170 80,409 Interest expense (income) and other, net (1) 85,074 37,950 (29) Pension settlement gain — (9,136) (11,208) Restructuring and other related charges (2) 24,110 23,096 18,954 Separation costs (3) — 15,545 2,865 Acquisition - amortization and other related charges (4) 36,851 34,196 35,949 Depreciation and other amortization 35,975 34,852 38,462 Adjusted EBITDA $ 501,102 $ 436,754 $ 404,081 (1) Relates to removal of interest expense, net included within the Interest expense (income) and other, net line within the Consolidated and Combined Statements of Operations. (2) I ncludes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expense, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines . (3) I ncludes non-recurrin g charges and employee costs related to the planning and execution of t he separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations. (4) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses. December 31, 2023 2022 (In thousands) Investments in Equity Method Investees: Americas $ — $ — EMEA & APAC 30,633 28,527 $ 30,633 $ 28,527 Total Assets: Americas $ 1,671,634 $ 1,666,799 EMEA & APAC 2,156,995 2,087,216 $ 3,828,629 $ 3,754,015
Schedule of Long-Lived Assets, by Geographical Areas	December 31, 2023 2022 (In thousands) Property, Plant and Equipment, Net (1) : United States $ 68,398 $ 68,380 Czech Republic 60,948 60,278 India 31,258 34,892 Russia 15,550 19,111 Mexico 23,922 17,666 Other foreign countries 94,229 83,899 $ 294,305 $ 284,226 (1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) $ in Thousands		12 Months Ended
	Apr. 04, 2022 USD ($) shares	Dec. 31, 2023 USD ($) segment	Dec. 31, 2022 USD ($)
Concentration Risk [Line Items]
Number of reportable segments \| segment		2
Net income		$ 205,285
Stockholders' Equity Attributable to Parent		(1,607,399)	$ (1,350,207)
Foreign Currency Translation Adjustment
Concentration Risk [Line Items]
Stockholders' Equity Attributable to Parent		115,000
Russia
Concentration Risk [Line Items]
Net income		$ 12,000
Russia \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Concentration Risk [Line Items]
Concentration risk (as a percent)		6%
Russia \| Assets, Total \| Geographic Concentration Risk
Concentration Risk [Line Items]
Concentration risk (as a percent)		4%
The Credit Agreement
Concentration Risk [Line Items]
Indebtedness incurred	$ 1,200,000
Enovis Corporation
Concentration Risk [Line Items]
Number of shares sold \| shares	6,000,000
ESAB Corporation \| Enovis Corporation
Concentration Risk [Line Items]
Ownership percentage by noncontrolling owners	10%
Common Stock
Concentration Risk [Line Items]
Percentage of outstanding stock after spin-off	90%
Common Stock \| Enovis Corporation
Concentration Risk [Line Items]
Number of shares recapitalized \| shares	0.333

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	12 Months Ended
	Dec. 31, 2023 USD ($) reporting_unit	Dec. 31, 2022 USD ($) reporting_unit	Dec. 31, 2021 USD ($)
Incremental costs of obtaining a contract, period	1 year
Research and development costs	$ 38,800,000	$ 36,000,000	$ 39,700,000
LIFO inventory amount	107,800,000	131,100,000
Reserve for excess and obsolete inventory	$ 47,587,000	$ 40,090,000
Number of reporting units \| reporting_unit	3	2
Goodwill impairment	$ 0	$ 0	0
Foreign exchange gain (loss)	13,108,000	2,706,000	2,386,000
Interest income	8,700,000	700,000
Trade names
Impairment of intangible assets, indefinite-lived	0	0	0
Selling, general and administrative expense
Foreign exchange gain (loss)	11,389,000	2,597,000	2,195,000
Interest expense and other, net
Foreign exchange gain (loss)	1,719,000	109,000	$ 191,000
Argentina, Pesos \| Cost of Sales
Foreign exchange gain (loss)	11,500,000	6,600,000
Argentina, Pesos \| Selling, general and administrative expense
Foreign exchange gain (loss)	6,700,000	3,300,000
Argentina, Pesos \| Interest expense and other, net
Foreign exchange gain (loss)	$ 26,200,000	$ 2,400,000
Minimum \| Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements
Intangible asset, useful life (in years)	10 years
Maximum \| Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements
Intangible asset, useful life (in years)	30 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	$ 13,108	$ 2,706	$ 2,386
Selling, general and administrative expense
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	11,389	2,597	2,195
Selling, general and administrative expense \| Argentina, Pesos
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	6,700	3,300
Interest expense and other, net
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	1,719	109	$ 191
Interest expense and other, net \| Argentina, Pesos
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	26,200	2,400
Cost of Sales \| Argentina, Pesos
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	$ 11,500	$ 6,600

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from discontinued operations, net of taxes	$ (12,341)	$ (3,068)	$ 0
Cash used in operating activities, discontinued operations	15,200	23,100
Asbestos Related Activity
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from discontinued operations, net of taxes	15,600	7,500
Income tax benefit	$ 3,300	$ 4,400

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands				12 Months Ended
Acquisitions (Details) - USD ($) $ in Thousands	Jan. 11, 2023	Oct. 31, 2022	Oct. 14, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Cash consideration, net of cash received				$ 18,665	$ 149,029	$ 4,885
Therapy Equipment Limited
Business Acquisition [Line Items]
Cash consideration, net of cash received	$ 19,000
Swift Cut Automation Limited
Business Acquisition [Line Items]
Cash consideration, net of cash received		$ 22,000
Ohio Medical, LLC
Business Acquisition [Line Items]
Cash consideration, net of cash received			$ 127,000

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Net sales	$ 2,774,766	$ 2,593,480	$ 2,428,115
Equipment
Disaggregation of Revenue [Line Items]
Net sales	1,919,817	740,824	758,267
Consumables
Disaggregation of Revenue [Line Items]
Net sales	$ 854,949	$ 1,852,656	$ 1,669,848

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract liability	$ 31.2	$ 25.9	$ 22.3

Revenue - Allowance for Credit

Revenue - Allowance for Credit Loss Rollforward (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	$ 23,471
Charged to Expense, net	3,902
Write-Offs and Deductions	(2,289)
Foreign Currency Translation	393
Balance at End of Period	$ 25,477

Earnings per Share from Conti_3

Earnings per Share from Continuing Operations (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	Apr. 04, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Computation of earnings per share from continuing operations - basic:
Income from continuing operations attributable to ESAB Corporation		$ 217,626	$ 226,815	$ 235,110
Less: distributed and undistributed earnings allocated to nonvested shares		(1,555)	(1,600)	0
Income from continuing operations attributable to common stockholders		$ 216,071	$ 225,215	$ 235,110
Weighted-average shares of common stock outstanding - basic (in shares)	60,034,311	60,233,623	60,054,930	60,034,311
Income per share from continuing operations – basic (in dollars per share)		$ 3.59	$ 3.75	$ 3.92
Computation of earnings (loss) per share from continuing operations - diluted:
Net effect of potentially dilutive securities (in shares)		422,123	98,129	0
Weighted-average shares of common stock outstanding - assuming dilution (in shares)		60,655,746	60,153,059	60,034,311
Income per share from continuing operations – assuming dilution (in dollars per share)		$ 3.56	$ 3.74	$ 3.92
Income attributable to noncontrolling interest, net of taxes		$ 5,739	$ 4,266	$ 3,569

Income Taxes - Components of In

Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income from continuing operations before income taxes:
Domestic operations	$ 37,364	$ (19,234)	$ 10,140
Foreign operations	281,728	319,485	308,948
Income from continuing operations before income taxes	319,092	300,251	319,088
Current:
Federal	18,034	8,928	18,477
State	3,760	2,451	1,797
Foreign	99,036	77,728	68,779
Current income tax	120,830	89,107	89,053
Deferred:
Federal	(11,897)	(7,501)	(12,700)
State	(1,341)	358	161
Foreign	(11,865)	(12,794)	3,895
Deferred Income Tax	(25,103)	(19,937)	(8,644)
Income tax expense	$ 95,727	$ 69,170	$ 80,409

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Taxes calculated at the United States federal statutory rate	$ 67,010	$ 63,053	$ 67,008
State taxes	1,630	2,809	1,933
Effect of tax rates on international operations	1,548	(9,010)	(8,879)
Changes in tax reserves	10,753	(350)	2,734
Non-taxable dividends	0	0	(46)
Research and development tax credits	(714)	(542)	(587)
Effect of United States taxation on international operations	1,527	310	(313)
Permanent differences, net	10,077	7,209	483
Provision to return	703	(7,055)	(7,415)
Withholding taxes	11,172	12,133	9,567
Capital gain	0	(3,655)	12,371
Valuation Allowance	(12,308)	4,503	3,737
Other	4,329	(235)	(184)
Income tax expense	$ 95,727	$ 69,170	$ 80,409

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Post-retirement benefit obligation	$ 1,350	$ 5,761
Expenses currently not deductible	52,526	36,320
Net operating loss carryforward	107,395	111,497
Tax credit carryforward	4,581	10,320
Depreciation and amortization	7,404	9,124
Inventory	12,238	5,685
Capitalized R&D Costs	18,178	14,160
Leases	23,987	22,713
Other	2,866	0
Valuation allowance	(79,354)	(88,202)
Deferred tax assets, net	151,171	127,378
Deferred tax liabilities:
Depreciation and amortization	(120,055)	(121,858)
Leases	(23,987)	(22,713)
Outside basis differences and other	(79,985)	(79,623)
Total deferred tax liabilities	(224,027)	(224,194)
Total deferred tax liabilities, net	$ (72,856)	$ (96,816)

Income Taxes - Deferred Tax A_2

Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Tax Examination [Line Items]
Other liabilities	$ (144,662)	$ (161,500)
Total deferred tax liabilities, net	(72,856)	(96,816)
Other Assets
Income Tax Examination [Line Items]
Other assets	46,602	42,860
Other Liabilities
Income Tax Examination [Line Items]
Other liabilities	$ (119,458)	$ (139,676)

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Examination [Line Items]
Percentage of liable taxes in a joint return	50%
Percentage of installment obligation liable by former parent	50%
Valuation allowance	$ 79,354	$ 88,202
Increase in valuation allowance	3,400
Decrease in valuation allowance	12,300
Net operating loss carryforward, subject to expiration	11,600
Tax expense relating to a distribution of earnings for which the indefinite reinvestment assertion has changed	10,900
Unrecognized tax benefits	30,871	20,203	$ 37,681	$ 35,201
Unrecognized tax benefits, income tax penalties and interest accrued	12,100	5,600	6,200
Unrecognized tax (benefits), income tax penalties and interest expense	(7,900)	$ 700	$ 900
Foreign Tax Authority
Income Tax Examination [Line Items]
Operating loss carryforwards	$ 414,600

Income Taxes - Gross Unrecogniz

Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning Balance	$ 20,203	$ 37,681	$ 35,201
Addition for tax positions taken in prior periods	13,514	1,971	738
Addition for tax positions taken in the current period	0	1,171	2,987
Reductions related to settlements with taxing authorities	(4,160)	(922)	(425)
Reductions resulting from a lapse of applicable statute of limitations	(473)		(565)
Transfer from Former Parent, impact of foreign currency translation and other		(2,801)
Other, including the impact of foreign currency translation and United States tax rate changes		(16,897)	(255)
Other, including the impact of foreign currency translation	1,787
Ending Balance	$ 30,871	$ 20,203	$ 37,681

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill [Roll Forward]
Balance beginning of period	$ 1,529,767	$ 1,532,993
Goodwill attributable to acquisition	15,576	76,230
Impact of foreign currency translation	42,988	(79,456)
Balance end of period	1,588,331	1,529,767
Americas Business Segment [Member]
Goodwill [Roll Forward]
Balance beginning of period	585,845	519,154
Goodwill attributable to acquisition	1,664	63,183
Impact of foreign currency translation	2,366	3,508
Balance end of period	589,875	585,845
EMEA & APAC
Goodwill [Roll Forward]
Balance beginning of period	943,922	1,013,839
Goodwill attributable to acquisition	13,912	13,047
Impact of foreign currency translation	40,622	(82,964)
Balance end of period	$ 998,456	$ 943,922

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Intangible Assets Schedule [Line Items]
Accumulated Amortization	$ (382,584)	$ (357,383)
Total intangible assets	882,119	874,550
Trade names
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	23,966	22,464
Accumulated Amortization	(10,983)	(9,412)
Customer relationships
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	496,483	482,499
Accumulated Amortization	(231,848)	(203,041)
Technology
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	73,288	71,192
Accumulated Amortization	(55,288)	(50,005)
Software
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	80,203	94,904
Accumulated Amortization	(61,920)	(74,799)
Other intangible assets
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	22,878	22,800
Accumulated Amortization	(22,545)	(20,126)
Trade names
Intangible Assets Schedule [Line Items]
Indefinite-Lived Intangible Assets	$ 185,301	$ 180,691

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 39.7	$ 35.6	$ 42.1

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Expected Amortization Expense (Details ) $ in Thousands	Dec. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year One	$ 29,160
Finite-Lived Intangible Asset, Expected Amortization, Year Two	28,115
Finite-Lived Intangible Asset, Expected Amortization, Year Three	27,027
Finite-Lived Intangible Asset, Expected Amortization, Year Four	22,562
2028	$ 20,782

Property, Plant and Equipment_3

Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 588,095	$ 563,141
Accumulated depreciation	(293,790)	(278,915)
Property, plant and equipment, net	294,305	284,226
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	15,095	15,839
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 178,682	164,472
Buildings and improvements \| Minimum
Property, Plant and Equipment [Line Items]
Depreciable Life	5 years
Buildings and improvements \| Maximum
Property, Plant and Equipment [Line Items]
Depreciable Life	40 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 394,318	$ 382,830
Machinery and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Depreciable Life	3 years
Machinery and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Depreciable Life	15 years

Property, Plant and Equipment_4

Property, Plant and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment
Property, Plant and Equipment [Line Items]
Depreciation and other amortization	$ 30	$ 29.5	$ 32.5

Inventories, Net (Details)

Inventories, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 156,583	$ 153,099
Work in process	43,561	44,086
Finished goods	244,580	261,902
Inventories, gross	444,724	459,087
LIFO reserve	(4,279)	(2,168)
Less: allowance for excess, slow-moving and obsolete inventory	(47,587)	(40,090)
Inventories, net	$ 392,858	$ 416,829
Percentage of inventory valued at LIFO	27.40%	31.50%

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	12 Months Ended
Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease expense	$ 25,400	$ 21,300	$ 23,000
Future lease payments by year:
2024	25,769
2025	20,540
2026	14,366
2027	9,938
2028	8,645
Thereafter	32,190
Total	111,448
Less: present value discount	(12,045)
Present value of lease liabilities	$ 99,403
Lessee, Operating Lease, Remaining Lease Term	6 years 7 months 13 days
Operating leases	3.50%

Accrued and Other Liabilities -

Accrued and Other Liabilities - Current and Noncurrent (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
CURRENT LIABILITIES:
Accrued taxes and deferred tax liabilities	$ 45,681	$ 49,615
Compensation and related benefits	97,052	74,794
Asbestos liability	32,908	30,108
Contract liability	31,248	25,899
Lease liability	22,794	18,664
Warranty liability	12,606	12,946
Third-party commissions	18,711	18,315
Restructuring liability	5,345	7,533
Other	47,144	47,436
Accrued liabilities	$ 313,489	$ 285,310
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities
Liabilities, Noncurrent [Abstract]
Accrued taxes and deferred tax liabilities	$ 144,662	$ 161,500
Compensation and related benefits	52,589	57,438
Asbestos liability	234,796	230,581
Contract liability	$ 0	$ 0
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Total accrued and other liabilities, Noncurrent	Total accrued and other liabilities, Noncurrent
Lease liability	$ 76,609	$ 76,163
Warranty liability	0	0
Third-party commissions	0	0
Restructuring liability	354	285
Other	33,823	19,372
Total accrued and other liabilities, Noncurrent	$ 542,833	$ 545,339

Accrued and Other Liabilities_2

Accrued and Other Liabilities - Warranty Liability Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 01, 2023	Dec. 31, 2023	Dec. 31, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]
Warranty liability, beginning of period	$ 12,946	$ 12,946	$ 14,954
Accrued warranty expense	5,794		5,322
Changes in estimates related to pre-existing warranties	3,097		2,821
Cost of warranty service work performed	$ (10,710)		(9,680)
Acquisition-related liability		1,278	0
Foreign exchange translation effect		201	(471)
Warranty liability, end of period		$ 12,606	$ 12,946

Accrued and Other Liabilities_3

Accrued and Other Liabilities - Restructuring Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restructuring Reserve [Roll Forward]
Restructuring Charges, Total	$ 24,110	$ 23,096	$ 18,954
Americas Business Segment [Member]
Restructuring Reserve [Roll Forward]
Balance at Beginning of Period	7,818	8,109
Charges	18,654	22,298
Payments	(20,706)	(22,694)
Foreign Currency Translation	(67)	105
Balance at End of Period	5,699	7,818	8,109
Non cash charges	5,456	798
Restructuring Charges, Total	24,110	23,096
Termination Benefits \| Americas Business Segment [Member]
Restructuring Reserve [Roll Forward]
Balance at Beginning of Period	4,910	7,818
Charges	10,017	4,642
Payments	(10,223)	(7,626)
Foreign Currency Translation	(109)	76
Balance at End of Period	4,595	4,910	7,818
Facility Closure Costs \| Americas Business Segment [Member]
Restructuring Reserve [Roll Forward]
Balance at Beginning of Period	2,908	291
Charges	8,637	17,656
Payments	(10,483)	(15,068)
Foreign Currency Translation	42	29
Balance at End of Period	$ 1,104	$ 2,908	$ 291

Benefit Plans - Narrative (Deta

Benefit Plans - Narrative (Details) $ in Thousands	12 Months Ended
Benefit Plans - Narrative (Details) $ in Thousands	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) plan	Dec. 31, 2021 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of plans merged \| plan		2
Number of plans after merging plans \| plan		1
Pension settlement gain	$ 0	$ 9,136	$ 11,208
Plans with accumulated benefit obligations in excess of plan assets, accumulated benefit obligation	50,700	201,100
Plans with accumulated benefit obligations in excess of plan assets, fair value of plan assets	3,900	149,800
Plans with projected benefit obligations in excess of plan assets, projected benefit obligation	55,600	206,800
Plans with projected benefit obligations in excess of plan assets, fair value of plan assets	7,000	154,100
Expected employer contributions in the next fiscal year	$ 5,200
Weighted-average annual rate of increase (as a percent)	7.50%
Health care cost trend rate (as a percent)	4%
Defined contribution plan, cost	$ 7,600	8,700	7,900
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	211,472	219,050
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	211,472	219,050	84,503
Change in benefit obligation:	242,743	256,022	142,914
Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss	61,492	70,954
Pension settlement gain	0	9,114	11,195
Pension Benefits \| Former Parent
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets		201,300
Change in benefit obligation:		$ 200,700
Number of defined benefit plans \| plan		1
Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss		$ 100
Pension Benefits \| Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	65,278	70,821	84,503
Change in benefit obligation:	99,215	99,401	141,278
Pension settlement gain	0	9,114	11,195
Other Post-Retirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0	0
Change in benefit obligation:	8,190	8,850	382
Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss	(5,234)	(5,199)
Pension settlement gain	$ 0	0	$ (8)
Other Post-Retirement Benefits \| Former Parent
Defined Benefit Plan Disclosure [Line Items]
Change in benefit obligation:		$ 11,700
Number of defined benefit plans \| plan		1

Benefit Plans - Obligation and

Benefit Plans - Obligation and Asset Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Change in plan assets:
Employer contribution from refund of assets	$ 5,100
Pension settlement gain	0	$ 9,136	$ 11,208
Foreign Plan
Change in plan assets:
Fair value of plan assets, beginning of year	219,050
Fair value of plan assets, end of year	211,472	219,050
Pension Benefits
Change in benefit obligation:
Projected benefit obligation, beginning of year	256,022	142,914
Transfer from Former Parent	0	200,690
Service cost	1,439	1,684	1,785
Interest cost	11,170	5,874	1,668
Plan amendments	175	862
Actuarial loss (gain)	802	(60,148)
Foreign exchange effect	4,079	(12,452)
Benefits paid	(27,720)	(23,385)
Settlements	(3,584)	(283)
Other	360	266
Projected benefit obligation, end of year	242,743	256,022	142,914
Accumulated benefit obligation, end of year	239,578	253,123
Change in plan assets:
Fair value of plan assets, beginning of year	219,050	84,503
Transfer from Former Parent	0	201,259
Actual return on plan assets	19,651	(51,266)
Employer contributions	(857)
Employer contributions		5,315
Foreign exchange effect	3,162	(7,583)
Benefits paid	(27,720)	(23,385)
Settlements	(2,505)	9,947
Other	691	260
Fair value of plan assets, end of year	211,472	219,050	84,503
Funded status, end of year	(31,271)	(36,972)
Non-current assets	17,300	15,701
Current liabilities	(3,186)	(3,025)
Non-current liabilities	(45,385)	(49,648)
Total	(31,271)	(36,972)
Pension settlement gain	0	9,114	11,195
Pension Benefits \| Foreign Plan
Change in benefit obligation:
Projected benefit obligation, beginning of year	99,401	141,278
Service cost	1,439	1,684	1,785
Interest cost	4,148	2,161	1,646
Plan amendments	175	862
Actuarial loss (gain)	335	(25,131)
Foreign exchange effect	4,079	(12,452)
Benefits paid	(7,138)	(8,984)
Settlements	(3,584)	(283)
Other	360	266
Projected benefit obligation, end of year	99,215	99,401	141,278
Accumulated benefit obligation, end of year	96,049	96,500
Change in plan assets:
Fair value of plan assets, beginning of year	70,821	84,503
Actual return on plan assets	1,262	(12,494)
Employer contributions	(1,015)
Employer contributions		5,170
Foreign exchange effect	3,162	(7,581)
Benefits paid	(7,138)	(8,984)
Settlements	(2,505)	9,947
Other	691	260
Fair value of plan assets, end of year	65,278	70,821	84,503
Funded status, end of year	(33,937)	(28,580)
Pension settlement gain	0	9,114	11,195
Other Post-Retirement Benefits
Change in benefit obligation:
Projected benefit obligation, beginning of year	8,850	382
Transfer from Former Parent	0	11,697
Service cost	11	15	14
Interest cost	393	234	22
Plan amendments	0	0
Actuarial loss (gain)	(514)	(2,807)
Foreign exchange effect	(1)	(35)
Benefits paid	(549)	(636)
Settlements	0	0
Other	0	0
Projected benefit obligation, end of year	8,190	8,850	382
Accumulated benefit obligation, end of year	8,190	8,850
Change in plan assets:
Fair value of plan assets, beginning of year	0	0
Transfer from Former Parent	0	0
Actual return on plan assets	0	0
Employer contributions	549	636
Foreign exchange effect	0	0
Benefits paid	(549)	(636)
Settlements	0	0
Other	0	0
Fair value of plan assets, end of year	0	0	0
Funded status, end of year	(8,190)	(8,850)
Non-current assets	0	0
Current liabilities	(764)	(824)
Non-current liabilities	(7,426)	(8,026)
Total	(8,190)	(8,850)
Pension settlement gain	$ 0	$ 0	$ (8)

Benefit Plans - Expected Benefi

Benefit Plans - Expected Benefit Payments (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
2024	$ 21,183
2025	20,635
2026	20,300
2027	19,912
2028	19,134
2029 - 2033	89,736
Pension Benefits \| Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
2024	7,256
2025	7,074
2026	7,138
2027	7,175
2028	6,802
2029 - 2033	35,683
Other Post-Retirement Benefits
Defined Benefit Plan Disclosure [Line Items]
2024	764
2025	745
2026	744
2027	740
2028	688
2029 - 2033	$ 3,055

Benefit Plans - Plan Asset Allo

Benefit Plans - Plan Asset Allocation (Details)	Dec. 31, 2023	Dec. 31, 2022
Equity securities \| Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	1%	4%
United States \| United States
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	38%	36%
International \| United States
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	12%	13%
Fixed income \| United States
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	49%	50%
Fixed income \| Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	48%	34%
Cash and cash equivalents \| United States
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	1%	1%
Cash and cash equivalents \| Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	1%	16%
Insurance contracts \| Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	38%	34%
Investment funds \| Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	12%	12%

Benefit Plans - Plan Asset Al_2

Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
United States \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	$ 1,237	$ 1,591
United States \| United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	29,289	31,018
United States \| United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	26,163	22,078
United States \| International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	18,078	18,928
United States \| United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	70,283	73,497
United States \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	1,145	1,118
United States \| Measured at Net Asset Value \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Measured at Net Asset Value \| United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	29,289	31,018
United States \| Measured at Net Asset Value \| United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	10,130	10,789
United States \| Measured at Net Asset Value \| International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	18,078	18,928
United States \| Measured at Net Asset Value \| United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	70,283	73,497
United States \| Measured at Net Asset Value \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level One \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	1,237	1,591
United States \| Level One \| United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level One \| United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	16,033	11,289
United States \| Level One \| International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level One \| United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level One \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	1,145	1,118
United States \| Level Two \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Two \| United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Two \| United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Two \| International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Two \| United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Two \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Three \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Three \| United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Three \| United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Three \| International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Three \| United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States \| Level Three \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	211,472	219,050
Foreign Plan \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	547	11,348
Foreign Plan \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	921	2,475
Foreign Plan \| Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	31,147	24,289
Foreign Plan \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	24,592	24,236
Foreign Plan \| Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	8,050	8,400
Foreign Plan \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	20	72
Foreign Plan \| Measured at Net Asset Value
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	127,780	134,232
Foreign Plan \| Measured at Net Asset Value \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Measured at Net Asset Value \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Measured at Net Asset Value \| Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Measured at Net Asset Value \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Measured at Net Asset Value \| Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Measured at Net Asset Value \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level One
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	51,030	52,143
Foreign Plan \| Level One \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	547	11,348
Foreign Plan \| Level One \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	921	2,475
Foreign Plan \| Level One \| Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	31,147	24,289
Foreign Plan \| Level One \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level One \| Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level One \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	33
Foreign Plan \| Level Two
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	32,662	32,675
Foreign Plan \| Level Two \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Two \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Two \| Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Two \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	24,592	24,236
Foreign Plan \| Level Two \| Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	8,050	8,400
Foreign Plan \| Level Two \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	20	39
Foreign Plan \| Level Three
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Three \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Three \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Three \| Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Three \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Three \| Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan \| Level Three \| Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	$ 0	$ 0

Benefit Plans - Net Periodic Be

Benefit Plans - Net Periodic Benefit Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Components of Net Periodic Benefit (Income) Cost:
Settlement (gain) loss	$ 0	$ (9,136)	$ (11,208)
Pension Benefits
Components of Net Periodic Benefit (Income) Cost:
Service cost	1,439	1,684	1,785
Interest cost	11,170	5,874	1,668
Amortization	1,206	4,313	1,220
Settlement (gain) loss	0	(9,114)	(11,195)
Other	0	92	2
Expected return on plan assets	(11,391)	(11,519)	(2,258)
Net periodic benefit cost (income)	2,424	(8,670)	(8,778)
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Transfer from Former Parent	0	53,134	0
Current year net actuarial (gain) loss	(7,021)	949	(5,788)
Current year prior service cost	175	862	0
Less amounts included in net periodic benefit cost:
Amortization of net (loss) gain	(1,575)	(4,340)	(1,228)
Settlement/divestiture/other loss	(1,079)	(67)	0
Amortization of prior service cost	38	(1,067)	(5)
Total recognized in Other comprehensive loss (gain)	(9,462)	49,471	(7,021)
Other Post-Retirement Benefits
Components of Net Periodic Benefit (Income) Cost:
Service cost	11	15	14
Interest cost	393	234	22
Amortization	0	(181)	0
Settlement (gain) loss	0	0	8
Other	0	0	0
Expected return on plan assets	0	0	0
Net periodic benefit cost (income)	404	68	44
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Transfer from Former Parent	0	(2,629)	0
Current year net actuarial (gain) loss	(514)	(2,807)	(27)
Current year prior service cost	0	0	0
Less amounts included in net periodic benefit cost:
Amortization of net (loss) gain	479	181	(8)
Settlement/divestiture/other loss	0	0	0
Amortization of prior service cost	0	0	0
Total recognized in Other comprehensive loss (gain)	(35)	(5,255)	(35)
Foreign Plan \| Pension Benefits
Components of Net Periodic Benefit (Income) Cost:
Service cost	1,439	1,684	1,785
Interest cost	4,148	2,161	1,646
Amortization	40	687	1,118
Settlement (gain) loss	0	(9,114)	(11,195)
Other	(331)	92	2
Expected return on plan assets	(2,475)	(2,063)	(2,258)
Net periodic benefit cost (income)	2,821	(6,553)	(8,902)
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Current year net actuarial (gain) loss	1,984	(12,262)	(5,710)
Current year prior service cost	175	862	0
Less amounts included in net periodic benefit cost:
Amortization of net (loss) gain	(78)	(714)	(1,126)
Settlement/divestiture/other loss	(1,079)	(67)	0
Amortization of prior service cost	38	(1,067)	(5)
Total recognized in Other comprehensive loss (gain)	$ 1,040	$ (13,248)	$ (6,841)

Benefit Plans - Accumulated Oth

Benefit Plans - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Net actuarial loss (gain)	$ 61,573	$ 71,066
Prior service income	(81)	(112)
Total	61,492	70,954
Other Post-Retirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Net actuarial loss (gain)	(5,234)	(5,199)
Prior service income	0	0
Total	$ (5,234)	$ (5,199)

Benefit Plans - Key Economic As

Benefit Plans - Key Economic Assumptions (Details)	12 Months Ended
Benefit Plans - Key Economic Assumptions (Details)	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Weighted-average discount rate, benefit obligation	4.40%	4.60%
Weighted-average discount rate, net periodic benefit cost	4.60%	2.20%	1.30%
Weighted-average expected return on plan assets, net periodic benefit cost	5%	4.80%	3.60%
Other Post-Retirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Weighted-average discount rate, benefit obligation	4.80%	5%
Weighted-average discount rate, net periodic benefit cost	0%	2.60%	6%
Weighted-average expected return on plan assets, net periodic benefit cost	0%	0%	0%
Foreign Plan \| Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Weighted-average discount rate, benefit obligation	3.90%	4.30%
Weighted-average rate of increase in compensation levels for active foreign plans	3.10%	3.20%
Weighted-average discount rate, net periodic benefit cost	4.30%	1.90%	1.30%
Weighted-average expected return on plan assets, net periodic benefit cost	4.10%	3.20%	3.60%
Weighted-average rate of increase in compensation levels for active foreign plans, net periodic benefit cost	3.20%	3.20%	3.40%
Foreign Plan \| Other Post-Retirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Weighted-average discount rate, benefit obligation	0%	0%
Weighted-average rate of increase in compensation levels for active foreign plans	0%	0%
Weighted-average discount rate, net periodic benefit cost	0%	0%	0%
Weighted-average expected return on plan assets, net periodic benefit cost	0%	0%	0%
Weighted-average rate of increase in compensation levels for active foreign plans, net periodic benefit cost	0%	0%	0%

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total debt	$ 1,019,500	$ 1,221,000
Unamortized deferred financing fees	(2,300)
Long-term debt	1,018,057	1,218,643
Other Assets
Debt Instrument [Line Items]
Unamortized deferred financing fees	(900)
Long-term Debt
Debt Instrument [Line Items]
Unamortized deferred financing fees	(1,443)	(2,357)
Term loans \| The Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Total debt	987,500	1,000,000
Revolving credit facilities \| The Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Total debt	$ 32,000	$ 221,000

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	Apr. 04, 2022	Dec. 31, 2023	Dec. 31, 2022	Jun. 28, 2022
Debt Instrument [Line Items]
Letters of credit outstanding amount		$ 28,600,000
Unamortized deferred financing fees		2,300,000
Other Assets
Debt Instrument [Line Items]
Unamortized deferred financing fees		900,000
Long-term Debt
Debt Instrument [Line Items]
Unamortized deferred financing fees		$ 1,443,000	$ 2,357,000
Enovis Corporation
Debt Instrument [Line Items]
Cash consideration	$ 1,200,000,000
The Credit Agreement
Debt Instrument [Line Items]
Indebtedness incurred	$ 1,200,000,000
Weighted-average interest rate (as a percent)		5.223%
The Credit Agreement \| Minimum \| SOFR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.125%
The Credit Agreement \| Minimum \| Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.125%
The Credit Agreement \| Maximum \| SOFR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.75%
The Credit Agreement \| Maximum \| Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.75%
Revolving credit facilities \| The Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 750,000,000	$ 750,000,000
Proceeds from borrowings on revolving credit facility and other	200,000,000
Line of credit facility, remaining borrowing capacity		718,000,000
Term loans \| The Credit Agreement \| Senior Notes
Debt Instrument [Line Items]
Principal amount	$ 600,000,000	593,000,000		$ 600,000,000
Debt term (in days)	364 days
Indebtedness incurred	$ 600,000,000
Term loans \| The Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Principal amount	400,000,000	395,000,000
Indebtedness incurred	400,000,000
Letter of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		109,000,000
Letter of Credit \| The Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	300,000,000
Letter of Credit \| Uncommitted Credit Line
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 78,000,000
Swing Line Loan Sub-Facility \| The Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 50,000,000

Debt - Schedule of Debt Maturit

Debt - Schedule of Debt Maturities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
2024	$ 0
2025	592,500
2026	0
2027	427,000
2028	0
Long-term debt	1,019,500	$ 1,221,000
Unamortized deferred financing fees	2,300
Long-term Debt
Debt Instrument [Line Items]
Unamortized deferred financing fees	$ 1,443	$ 2,357

Derivatives - Narratives (Detai

Derivatives - Narratives (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)	Dec. 31, 2022 USD ($)	Jul. 22, 2022 agreement	Jul. 14, 2022 USD ($) agreement
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Increase derivative assets and liabilities	$ 1.2
Interest rate swap agreements
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of derivative instruments held \| agreement					2
Notional amount					$ 600
Fixed interest rate					3.293%
Basis spread on variable rate (as a percent)	1.25%	1.25%
Loss related to interest rate swap agreements	$ 6.7
Interest rate swap agreements \| Minimum
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Basis spread on variable rate (as a percent)					1.125%
Interest rate swap agreements \| Maximum
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Basis spread on variable rate (as a percent)					1.75%
Cross currency swap agreements
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of derivative instruments held \| agreement				2
Cross currency swap agreements \| Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	275	€ 270
Cross currency swap agreements \| Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 232.5		$ 260

Derivatives - Summary of the Ef

Derivatives - Summary of the Effects of Designated Cash Flow Hedges on the Company’s Consolidated and Combined Statements of Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Interest rate swap agreements \| Interest expense (income) and other, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
(Gain) loss recognized in the Consolidated and Combined Statements of Operations:	$ (11,053)	$ 413

Derivatives - Schedule of Fair

Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other Liabilities	$ 22,232	$ 10,769
Other Assets	9,522	14,342
Cross currency swap agreements
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other Liabilities	22,232	10,769
Other Assets	0	0
Interest rate swap agreements
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Realized loss	(4,779)	(2,181)
Other Liabilities	0	0
Other Assets	$ 9,522	$ 14,342

Derivatives - Derivatives Not D

Derivatives - Derivatives Not Designated as Hedging Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Foreign currency contracts \| Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative liability, current	$ 596	$ 2,166
Derivative asset, current	$ 1,088	$ 3,682

Derivatives - Not Designated as

Derivatives - Not Designated as Hedging Instruments (Details) - Cross currency swap agreements - Not Designated as Hedging Instrument - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Change in unrealized (loss) gain	$ (1,023)	$ 1,338	$ 177
Realized loss	$ (2,928)	$ (17,601)	$ (5,631)

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Assets:
Cash equivalents	$ 6,027	$ 8,195
Deferred Compensation Plan Assets	3,488	2,501
Total assets at fair value	21,298	28,720
Liabilities:
Deferred compensation plans	3,488	2,501
Total liabilities at fair value	27,489	15,436
Cross currency swap agreements \| Not Designated as Hedging Instrument
Assets:
Derivative Asset	2,261	3,682
Liabilities:
Derivative liabilities	1,769	2,166
Cross currency swap agreements \| Designated as Hedging Instrument
Liabilities:
Derivative liabilities	22,232	10,769
Interest rate swap agreements
Assets:
Derivative Asset	9,522	14,342
Level One
Assets:
Cash equivalents	6,027	8,195
Deferred Compensation Plan Assets	0	0
Total assets at fair value	6,027	8,195
Liabilities:
Deferred compensation plans	0	0
Total liabilities at fair value	0	0
Level One \| Cross currency swap agreements \| Not Designated as Hedging Instrument
Assets:
Derivative Asset	0	0
Liabilities:
Derivative liabilities	0	0
Level One \| Cross currency swap agreements \| Designated as Hedging Instrument
Liabilities:
Derivative liabilities	0	0
Level One \| Interest rate swap agreements
Assets:
Derivative Asset	0	0
Level Two
Assets:
Cash equivalents	0	0
Deferred Compensation Plan Assets	3,488	2,501
Total assets at fair value	15,271	20,525
Liabilities:
Deferred compensation plans	3,488	2,501
Total liabilities at fair value	27,489	15,436
Level Two \| Cross currency swap agreements \| Not Designated as Hedging Instrument
Assets:
Derivative Asset	2,261	3,682
Liabilities:
Derivative liabilities	1,769	2,166
Level Two \| Cross currency swap agreements \| Designated as Hedging Instrument
Liabilities:
Derivative liabilities	22,232	10,769
Level Two \| Interest rate swap agreements
Assets:
Derivative Asset	9,522	14,342
Level Three
Assets:
Cash equivalents	0	0
Deferred Compensation Plan Assets	0	0
Total assets at fair value	0	0
Liabilities:
Deferred compensation plans	0	0
Total liabilities at fair value	0	0
Level Three \| Cross currency swap agreements \| Not Designated as Hedging Instrument
Assets:
Derivative Asset	0	0
Liabilities:
Derivative liabilities	0	0
Level Three \| Cross currency swap agreements \| Designated as Hedging Instrument
Liabilities:
Derivative liabilities	0	0
Level Three \| Interest rate swap agreements
Assets:
Derivative Asset	$ 0	$ 0

Equity - Accumulated Other Comp

Equity - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,388,458	$ 2,501,728	$ 2,544,767
Other comprehensive income (loss) before reclassifications:
Foreign currency translation adjustment	47,258	(175,719)	(72,398)
Other comprehensive income (loss)	50,864	(158,425)	(65,741)
Ending balance	1,647,657	1,388,458	2,501,728
Accumulated Other Comprehensive Loss
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(674,988)	(460,888)	(396,203)
Other comprehensive income (loss) before reclassifications:
Amounts contributed by Former Parent		(59,263)
Net actuarial gain	8,969	113	7,479
Foreign currency translation adjustment	(23,307)	(88,975)	(71,333)
Gain (loss) on long-term intra-entity foreign currency transactions	70,428	(83,105)
Unrealized gain on cash flow hedges	4,834	10,782
Other comprehensive (loss) income before reclassifications	60,924	(220,448)	(63,854)
Amounts reclassified from Accumulated other comprehensive loss	(10,208)	6,348	(831)
Net current period Other comprehensive (loss) income		(214,100)
Other comprehensive income (loss)	50,716	(154,837)	(64,685)
Ending balance	(624,272)	(674,988)	(460,888)
Net Unrecognized Pension and Other Post-Retirement Benefit Cost
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(63,847)	(21,196)	(29,378)
Other comprehensive income (loss) before reclassifications:
Amounts contributed by Former Parent		(50,504)
Net actuarial gain	8,969	113	7,479
Foreign currency translation adjustment	(3,285)	1,712	1,534
Gain (loss) on long-term intra-entity foreign currency transactions	0	0
Unrealized gain on cash flow hedges	0	0
Other comprehensive (loss) income before reclassifications	5,684	(48,679)	9,013
Amounts reclassified from Accumulated other comprehensive loss	(1,642)	6,028	(831)
Net current period Other comprehensive (loss) income		(42,651)
Other comprehensive income (loss)	4,042		8,182
Ending balance	(59,805)	(63,847)	(21,196)
Foreign Currency Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(613,907)	(439,692)	(366,825)
Other comprehensive income (loss) before reclassifications:
Amounts contributed by Former Parent		(8,759)
Net actuarial gain	0	0	0
Foreign currency translation adjustment	(11,143)	(82,351)	(72,867)
Gain (loss) on long-term intra-entity foreign currency transactions	70,428	(83,105)
Unrealized gain on cash flow hedges	0	0
Other comprehensive (loss) income before reclassifications	59,285	(174,215)	(72,867)
Amounts reclassified from Accumulated other comprehensive loss	0	0	0
Net current period Other comprehensive (loss) income		(174,215)
Other comprehensive income (loss)	59,285		(72,867)
Ending balance	(554,622)	(613,907)	(439,692)
Net Investment Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(8,336)	0	0
Other comprehensive income (loss) before reclassifications:
Amounts contributed by Former Parent		0
Net actuarial gain	0	0	0
Foreign currency translation adjustment	(8,879)	(8,336)	0
Gain (loss) on long-term intra-entity foreign currency transactions	0	0
Unrealized gain on cash flow hedges	0	0
Other comprehensive (loss) income before reclassifications	(8,879)	(8,336)	0
Amounts reclassified from Accumulated other comprehensive loss	0	0	0
Net current period Other comprehensive (loss) income		(8,336)
Other comprehensive income (loss)	(8,879)		0
Ending balance	(17,215)	(8,336)	0
Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	11,102	0	0
Other comprehensive income (loss) before reclassifications:
Amounts contributed by Former Parent		0
Net actuarial gain	0	0	0
Foreign currency translation adjustment	0	0	0
Gain (loss) on long-term intra-entity foreign currency transactions	0	0
Unrealized gain on cash flow hedges	4,834	10,782
Other comprehensive (loss) income before reclassifications	4,834	10,782	0
Amounts reclassified from Accumulated other comprehensive loss	(8,566)	320	0
Net current period Other comprehensive (loss) income		11,102
Other comprehensive income (loss)	(3,732)		0
Ending balance	$ 7,370	$ 11,102	$ 0

Equity - Narratives (Details)

Equity - Narratives (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
Equity - Narratives (Details) - USD ($) $ in Millions	Apr. 01, 2023	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expenses	$ 0.7		$ 2.6
Unrecognized stock-based compensation expense related to stock options		$ 2.3
Fair value of vested shares		8.9
Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expenses		$ 2.2
Unrecognized compensation cost, period for recognition (in years)		1 year 10 months 24 days
Performance Shares And Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, period for recognition (in years)		2 years
Unrecognized stock-based compensation expense		$ 18.4
PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expenses		$ 3.1
Award performance period		3 years
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance vesting period (in years)		3 years
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expenses		$ 9.8
Maximum \| Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum term (in years)		10 years

Equity - PRSU and RSU Activity

Equity - PRSU and RSU Activity (Details)	12 Months Ended
Equity - PRSU and RSU Activity (Details)	Dec. 31, 2023 $ / shares shares
PRSUs
Number of Units
Number of units, nonvested, beginning balance (in shares) \| shares	110,288
Granted (in shares) \| shares	(83,873)
Vested (in shares) \| shares	(19,062)
Forfeited and expired (in shares) \| shares	(6,124)
Number of units, nonvested, ending balance (in shares) \| shares	168,975
Weighted- Average Grant-Date Fair Value
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) \| $ / shares	$ 53.99
Awards converted from Former Parent plan (in usd per share) \| $ / shares	61.32
Granted (in usd per share) \| $ / shares	59.42
Vested (in usd per share) \| $ / shares	61.32
Forfeited and expired (in usd per share) \| $ / shares	$ 56.75
RSUs
Number of Units
Number of units, nonvested, beginning balance (in shares) \| shares	464,278
Granted (in shares) \| shares	(183,605)
Vested (in shares) \| shares	(152,907)
Forfeited and expired (in shares) \| shares	(55,346)
Number of units, nonvested, ending balance (in shares) \| shares	439,630
Weighted- Average Grant-Date Fair Value
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) \| $ / shares	$ 50.80
Awards converted from Former Parent plan (in usd per share) \| $ / shares	61.46
Granted (in usd per share) \| $ / shares	51
Vested (in usd per share) \| $ / shares	53.52
Forfeited and expired (in usd per share) \| $ / shares	$ 54.84

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Future claims period (in years)	15 years
Unconditional purchase obligation	$ 131.8

Commitments and Contingencies_2

Commitments and Contingencies - Claims Rollforward (Details)	12 Months Ended
	Dec. 31, 2023 USD ($) claim	Dec. 31, 2022 USD ($) claim
Loss Contingency Accrual [Roll Forward]
Claims unresolved, beginning of period	14,106	14,559
Claims filed	4,627	4,338
Claims resolved	(5,085)	(4,791)
Claims unresolved, end of period	13,648	14,106
Average cost of resolved claims \| $	$ 9,524	$ 10,017

Commitments and Contingencies_3

Commitments and Contingencies - Asbestos Litigation (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Long-term asbestos insurance asset	$ 221,489	$ 215,112
Long-term asbestos insurance receivable	17,868	17,231
Accrued asbestos liability	32,908	30,108
Asbestos liability	$ 234,796	$ 230,581

Segment Information - Narrative

Segment Information - Narratives (Details)	12 Months Ended
Segment Information - Narratives (Details)	Dec. 31, 2023 segment
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Information - Segment R

Segment Information - Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net sales	$ 2,774,766	$ 2,593,480	$ 2,428,115
Adjusted EBITDA	501,102	436,754	404,081
Depreciation, amortization and other impairment charges:	75,034	65,978	75,899
Capital expenditures:	48,178	40,243	35,584
Net income from continuing operations	223,365	231,081	238,679
Income tax expense	95,727	69,170	80,409
Interest expense and other, net	85,074	37,950
Interest income and other, net			(29)
Pension settlement gain	0	(9,136)	(11,208)
Restructuring and other related charges	24,110	23,096	18,954
Separation costs	0	15,545	2,865
Acquisition - amortization and other related charges	36,851	34,196	35,949
Depreciation and other amortization	35,975	34,852	38,462
Investments in Equity Method Investees:	30,633	28,527
Total Assets:	3,828,629	3,754,015
United States
Segment Reporting Information [Line Items]
Net sales	619,100	583,000	533,500
Americas
Segment Reporting Information [Line Items]
Net sales	1,214,998	1,128,306	1,004,208
Adjusted EBITDA	224,742	188,577	159,623
Depreciation, amortization and other impairment charges:	34,589	29,281	33,890
Capital expenditures:	21,576	18,005	14,095
Investments in Equity Method Investees:	0	0
Total Assets:	1,671,634	1,666,799
EMEA & APAC
Segment Reporting Information [Line Items]
Net sales	1,559,768	1,465,174	1,423,907
Adjusted EBITDA	276,360	248,177	244,458
Depreciation, amortization and other impairment charges:	40,445	36,697	42,009
Capital expenditures:	26,602	22,238	$ 21,489
Investments in Equity Method Investees:	30,633	28,527
Total Assets:	$ 2,156,995	$ 2,087,216

Segment Information - Net Sales

Segment Information - Net Sales and PPE by Geography (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 294,305	$ 284,226
United States
Segment Reporting Information [Line Items]
Property, plant and equipment, net	68,398	68,380
Czech Republic
Segment Reporting Information [Line Items]
Property, plant and equipment, net	60,948	60,278
India
Segment Reporting Information [Line Items]
Property, plant and equipment, net	31,258	34,892
Russia
Segment Reporting Information [Line Items]
Property, plant and equipment, net	15,550	19,111
Mexico
Segment Reporting Information [Line Items]
Property, plant and equipment, net	23,922	17,666
Other foreign countries
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 94,229	$ 83,899

Related Party Transactions (Det

Related Party Transactions (Details) - Related Party - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Apr. 01, 2022	Dec. 31, 2023	Dec. 31, 2022
License Of Improvements
Related Party Transaction [Line Items]
Related party transaction, period		2 years
Allocated Expenses From Former Parent
Related Party Transaction [Line Items]
Allocated expenses	$ 6		$ 29.5

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands				12 Months Ended
	Feb. 26, 2024	Feb. 22, 2024	Jan. 12, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Subsequent Event [Line Items]
Dividends payable				$ 3,600
Dividends paid				$ 13,342	$ 6,054	$ 0
Dividends on common stock (in dollars per share)				$ 0.23	$ 0.15
Subsequent Event
Subsequent Event [Line Items]
Dividends paid			$ 3,600
Dividends on common stock (in dollars per share)		$ 0.06
Subsequent Event \| Sager S.A.
Subsequent Event [Line Items]
Purchase price	$ 18,500

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Charged to Expense, net	$ 3,902
Transferred From Former Parent
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation allowance on deferred taxes	68,900
Allowance for credit losses
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	23,471	$ 23,912	$ 32,311
Charged to Expense, net	3,902	4,526	(494)
Write-Offs Write-Downs Deductions and Other	(2,289)	(4,978)	(6,931)
Foreign Currency Translation	393	11	(974)
Balance at End of Period	25,477	23,471	23,912
Valuation allowance for deferred tax assets
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	88,202	15,465	12,647
Charged to Expense, net	(12,283)	4,503	3,738
Write-Offs Write-Downs Deductions and Other	0	68,876	0
Foreign Currency Translation	3,436	(642)	(920)
Balance at End of Period	$ 79,355	$ 88,202	$ 15,465